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Foreword 
 
 Nanostructured materials have been the focus of scientific interest in recent years, 
because of the peculiar properties displayed by matter in nano-size form. The interest 
has been growing steeply since possible applications in biomedical fields have shown to 
be realistic. The interaction of magnetic nanoparticles with applied magnetic field 
gradients makes these particles attractive for their potential applications in biomedical 
imaging, diagnostic, and therapy. In this context, a great advantage are the 
superparamagnetic properties that can be exhibited by the nanoparticles. They behave 
as paramagnetic centres with high magnetic moment at room temperature, as it arises 
from the coupling of many atomic spins. After eliminating the external magnetic field, 
the particles no longer show magnetic interaction, thus reducing the possibility of 
particle aggregation; this feature is especially important for their applications. 
Biomedical use of magnetic nanoparticles imposes their uniform dispersion and stability 
in the biological fluids; moreover their size range should easily permit cell 
internalization through pinocytosis or endocytosis. Therefore, surface modification, via 
coating or encapsulation, is widely employed to improve nanoparticles properties and 
for immobilization of functional molecules. Magnetic nanoparticles have garnered 
widespread attention in recent years to develop and understand synthetic means to 
control their size, magnetic behaviour, and chemical reactivity. Simultaneously tuning 
surface chemistry and physical properties enable preparation of functional magnetic 
nanoparticles. Recent advances in synthesis have allowed to easily prepare a wide range 
of magnetic nanoparticles though aqueous or non aqueous approaches. It has been 
widely shown that the non-aqueous routes are more efficient in producing stable 
colloidal nanoparticles with narrow size distribution, high crystallinity, tunable size and 
shape. However, this approach typically produces hydrophobic nanoparticles limiting 
their applications in biological and medical fields. Thus, the transformation of these 
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hydrophobic nanoparticles into hydrophilic is a crucial step toward their widespread 
use. 
 
 The aim of the present PhD research project is to give a contribution to 
implement synthetic approaches to develop novel colloidal magnetic nano-architectures 
with applications in biomedical field. In particular, the research moves along two 
principal themes. From one side it has been investigated the possibility to tune magnetic 
nanoparticles size and properties through appropriate synthetic methodologies. From 
the other side, since the selected synthetic approach provides hydrophobic 
nanoparticles, particular attention has been devoted to the surface modification with 
organic and inorganic coatings in order to convert them into water dispersible systems. 
To this end, a multi-technique approach is used. A first structural analysis is performed 
by wide-angle X-ray Diffraction to obtain information about the crystalline phases and 
the crystallite size (coherent domain). Direct images of the samples, obtained by 
Transmission Electron Microscopy observations allowed an evaluation of the particle 
sizes, their distribution and the homogeneity of the particle dispersions. 
In order to study the magnetic-nanoparticles/coating interface, studies with 
FT-IR spectroscopy have been performed on hydrophobic nanoparticles and on all the 
systems in which the surface modification has been applied. To investigate the textural 
properties of the silica based composites nitrogen physisorption measurements have 
been performed in combination with low-angle X-ray diffraction to evidence the ordered 
porosity. Magnetic measurements have been acquired in order to understand how the 
different chemical composition, size and coatings can affect the magnetic properties of 
nanoparticles. 
All the measurements have been carried out at the Department of Chemical and 
Geological Sciences at the University of Cagliari. 
 
The present thesis is structured as follow: after an introduction on magnetic 
nanoparticle applications and properties (chapter 1), the chapter 2  is devoted to the 
magnetic nanoparticles with a special emphasis on the different surface chemical 
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modification processes  for their transferring into water environment. In the chapter 3 a 
synthetic approach based on a surfactant-assisted high-temperature thermal 
decomposition of metallorganic compounds is described in order to prepare 
hydrophobic magnetite and cobalt ferrite  nanoparticles with different sizes, narrow 
particle size distributions and tuned magnetic properties. Magnetite is an ideal 
candidate material because of its documented biocompatibility and high saturation 
magnetization, cobalt ferrite has been also chosen because of its known large magnetic 
anisotropy compared to other ferrites, in spite of highly toxic cobalt. In the chapter 4 
magnetic nanoparticles possessing a hydrophobic surface are transferred into water 
through molecular coatings. Oleic acid/oleylamine molecules, bound to the surface of 
magnetic nanoparticles, are substituted (ligand–exchange) by molecules possessing a 
dual functionality that allows their dispersion in water. The selected molecules are 
short-chain dicarboxylic acids or alkylsilanes. These molecules form a coating on the 
surface of the magnetic nanoparticles via carboxylic or Me-O-Si bonds, ensuring their 
stability in aqueous environment, as well as creating the conditions for a their possible 
conjugation with biologically active molecules. The hydrophobic nanoparticles is 
converted into hydrophilic also through the intercalation process with suitable 
surfactants such as cetyltrimethylammonium bromide (CTAB). These “magnetic pseudo 
micelles” build up of an inorganic core (magnetite or cobalt ferrite) and an organic shell 
(oleic acid-oleylamine-CTAB) are stable in water and can be employed in biological 
field. In the chapter 5 pure CTAB micelles are also used as organic templates for the 
formation of colloidal mesostructured silica nanoparticles through a base-catalyzed sol-
gel process. The hybrid-organic-inorganic “magnetic pseudo micelles”, have been proposed as 
building blocks for the creation, through the self assembling processes, of colloidal 
magnetic mesostructured silica nanoparticles with hexagonal or cubic pore structure. 
Silica is stable, biocompatible and hydrophilic, and if prepared in the form of 
mesostructured nanoparticles, showing high surface area and high pore volume, allows 
to incorporate an high number of magnetic nanoparticles, and to associate to the 
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magnetic properties other properties by entrapping fluorescent molecules, quantum 
dots, or luminescent nanoparticles.  
Due to their peculiar features, these colloidal magnetic nanocarriers can be 
considered promising versatile multifunctional systems for applications in theranostic 
as well as in bimodal (magnetic and optic) imaging applications. For these reasons, at 
last, some general comments and future insights are given. 
The appendix reports the details of the equipments and the methods. 
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Chapter 1 
Magnetic Metal Oxide Nanoparticles  
in Biomedical Applications 
 
 
This chapter gives general information about properties of magnetic nanomaterials, synthesis 
approaches and  biomedical applications. It provides the background for understanding and 
exploring the biomedical applications of magnetic nanoparticles. 
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Chapter 1 
Magnetic Metal Oxide Nanoparticles  
in Biomedical Applications 
 
1.0 Magnetic Metal Oxide Nanoparticles and Biomedical Applications 
 1.1 Introduction 
The development of novel materials is a fundamental focal point of chemical research; 
and this interest is mandated by advancements in all areas of industry and technology. 
Therefore in the last decade, the scientific research has focused on the development of 
new materials at the atomic, molecular, or macromolecular levels, on the length scale of 
approximately 1-100 nm. These research efforts are expected to provide a fundamental 
understanding of phenomena and materials at the nanoscale and to create and use 
structures, devices, and systems that have novel properties and functions due to their 
small and/or intermediate size, typically under 100 nm.[1] Successful application of 
nanoparticles not only depends on the special properties exhibited at this scale such as 
an enhanced electronic, mechanical, and chemical response but also on their 
manipulation to achieve specific objectives. In this sense, magnetic nanoparticles offer a 
range of opportunities as their response can be tailored by choosing from a variety of 
magnetic materials with different magnetic properties that can be manipulated by the 
use of external magnetic fields and by modification of their surfaces with molecules 
specific for intended applications.  
Magnetic nanoparticles are a major class of nanoscale materials with the 
potential to revolutionize current clinical diagnostic and therapeutic techniques. Due to 
their unique physical properties and ability to function at the cellular and molecular 
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level of biological interactions, they are being actively investigated as the next 
generation of magnetic resonance imaging (MRI) contrast agents[2],  as carriers for 
targeted drug delivery[3], in the hyperthermia[4] and as magnetic separation agent.[5] This 
because, first, they have sizes that place them at dimensions comparable to those of a 
virus (20–500 nm), a protein (5–50 nm) or a gene (2 nm wide and 10–100 nm long). 
Second, the nanoparticles are magnetic, which means that they obey Coulomb’s law, and 
can be manipulated by an external magnetic field gradient. Third and finally, 
nanoparticles have a large surface that can be properly modified to attach biological 
agents. Applications in biotechnology impose strict requirements on the particles’ 
physical, chemical and pharmacological properties, including chemical composition, 
granulometric uniformity, crystal structure, magnetic behavior, surface structure, 
adsorption properties, solubility and low own toxicity. For example, in order for 
magnetic drug-targeting to be safe and effective (with the minimum amount of magnetic 
particles, a maximum of drug should be easily administered and transported to a specific 
site), the following parameters of the nanomagnets are critical: (a) particle size (small as 
possible to improve tissular diffusion, and to have long sedimentation times and high 
effective surface areas), (b) surface characteristics (easy encapsulation of the magnetic 
nanoparticles protects them from degradation and endows biocompatibility), and (c) 
good magnetic response (possibility of decreasing nanomagnets concentration in blood 
and therefore diminishing the associated side effects).[6] Although early research in the 
field can be dated back several decades, the recent surge of interest in nanotechnology 
has significantly expanded the breadth and depth of magnetic nanoparticles research. 
With a wide range of applications in the detection, diagnosis, and treatment of illnesses, 
such as cancer[7], cardiovascular disease[8], and neurological disease[9], Magnetic 
nanoparticles may soon play a significant role in meeting the healthcare needs of 
tomorrow.[10] 
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1.2 Superparamagnetic Nanoparticles  
The penetration of magnetic fields through human tissue and the ability to remotely 
detect or manipulate magnetic materials have been investigated for use in medicine for 
centuries.[11] To better understand the advantages of using the magnetic nanoparticles in 
biomedical field we review some of the fundamental concepts of magnetism and the 
properties of nanoparticles. More thorough and detailed discussion of this topic can be 
found in the literature.[12] The classification of a material's magnetic properties is based 
on its magnetic susceptibility (χ), which is defined by the ratio of the induced 
magnetization (M) to the applied magnetic field (H). In diamagnetic materials, the 
magnetic moment is antiparallel to H resulting in very small and negative 
susceptibilities (−10−6 to −10−3). They do not retain magnetic properties when the 
external field is removed. Materials with magnetic moments aligned parallel to H and 
susceptibilities on the order of 10−6 to 10−1 are described as paramagnetic. While in ferri- 
and ferromagnetic materials, magnetic moments also align parallel to H, coupling 
interactions between the electrons of the material result in ordered magnetic states, i.e., 
magnetic domains, and large spontaneous magnetization. The susceptibilities of these 
materials depend on their atomic structures, temperature, and the external field H. If we 
now reduce the size of the ferromagnetic material we may ultimately reach a size where 
thermal energy (KBT= 4*10
-21 at 300 K) can randomize the magnetization, such that 
when there is no externally applied field the magnetization measured in a finite time 
interval (typically, 100 s) is zero. Such materials, at small sizes (on the order of 
nanometers), show no coercivity and behave as a single paramagnetic domain with a 
large magnetic moment, known with the name of  superparamagnets (figure 1(a) and (c)). 
The randomization of the magnetization takes place by excitation over an energy barrier 
given by the product of the anisotropy constant, K, and the volume, V. Note that the 
relaxation time, τ, depends exponentially on the energy barrier, KV, and hence to 
reproducibly control the magnetic behavior of superparamagnetic nanoparticles,  
narrow size distributions are required (figure 1 (b)). A superparamagnet is defined as an 
assembly of giant magnetic moments which are not interacting, and which can fluctuate 
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when the thermal energy, kBT, is larger than the anisotropy energy. However, at 
sufficiently high temperatures (i.e., blocking temperature TB) thermal energy is 
sufficient to induce free rotation of the particle resulting in a loss of net magnetization in 
the absence of an external field. This superparamagnetic property, marked by the lack of 
remanent magnetization after removal of external fields, enables the particles to 
maintain their colloidal stability and avoid aggregation making it feasible for their use in 
biomedical applications. Furthermore, the coupling interactions within these single 
magnetic domains result in much higher magnetic susceptibilities than paramagnetic 
materials. 
 
Figure 1. Magnetic behavior of materials: ferromagnetic materials (FM) are characterized by exchange 
interaction,  hysteretic behavior and a finite coercivity, Hc, paramagnetic materials (PM) the non-
interacting spins are characterized by a linear susceptibility that is inversely dependent on the 
temperature (Curie law), superparamagnetic materials (SPM), below a certain critical size the 
multidomain (FM) becomes a single domain superparamagnetic (a); and the superparamagnetic  
nanoparticles exhibit no remanence or coercivity, that is, there is no hysteresis in the magnetization 
curve (c). 
 
Although superparamagnetism is a favorable property of small particles, the reduction of 
particle size is not without some consequences. As particle sizes decrease, surface-to-
volume ratios increase resulting in pronounced surface effects, such as noncollinear 
spins, spin canting, and spin-glass-like behavior, which can significantly impact the 
magnetic properties of the material.[13] Typically, the saturation magnetization (Ms) 
values of nanoparticles, corresponding to the complete alignment of all individual 
(c) 
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moments in a sample, are smaller than their corresponding bulk phases due to 
disordered crystal structure resulting from high surface curvature, which increases with 
particle size reduction. Furthermore, significant differences in magnetic properties are 
observed with superparamagnetic nanoparticles obtained through different chemical 
processes. More detailed explanations of the physical properties of superparamagnetic 
nanoparticles and nanoscale magnetic phenomena can be found in recent reviews.[14,15,16]  
The magnetic behaviour of an assembly of nanoparticles is related to the crystalline 
structure. Among the different nanostructured magnetic materials, the metal oxide, such 
as magnetite (Fe3O4) and cobalt ferrite (CoFe2O4), with spinel structure (Me
IIMe2
IIIO4) 
represent probably the most promising class in biomedical application, because the rich 
crystal chemistry of spinels offers excellent opportunities for fine-tuning the magnetic 
properties. These have a face-centered cubic (fcc) structure in which the oxygen atoms 
are cubic close-packed. The structure contains two interstitial sites, occupied by metal 
cations, with tetrahedral, (A)-site, and octahedral, [B]-site, oxygen coordination, 
resulting in a different local symmetry (figure 2).  
  
Figure 2. Schematic representation of spinel structure. 
 
When the (A)-sites are occupied by MeII cations and the [B]-sites by MeIII cations, the 
structure is referred to as normal spinel, (MeII) [MeIII]. However, if the A sites are 
completely occupied by MeIII and the B-sites are randomly occupied by MeII and MeIII, 
then the structure is referred to as inverse spinel, (MeIII) [MeIII MeII]. In general, the 
cationic distribution in octahedral and tetrahedral sites is quantified by the “inversion 
degree” (γ), which is defined as the fraction of divalent ions in octahedral sites.[17,18] 
Tetrahedral site Octahedral site 
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1.3 Synthesis Techniques: Iron Oxide Nanoparticles 
It has long been of scientific and technological challenge to synthesize the magnetic 
nanoparticles of customized size and shape. Physical methods such as gas phase 
deposition and electron beam lithography are advantageous in that they produce 
nanomaterials of high purity and are applicable to large-scale production, but 
unfortunately are elaborate procedures that suffer from the inability to control the size 
of particles in the nanometer size range.[19] The wet chemical routes to magnetic 
nanoparticles are simpler, more tractable and more efficient with appreciable control 
over size, composition and sometimes even the shape of the nanoparticles.[20] 
The most common methods including sol-gel,[21,22] co-precipitation,[23,24] thermal 
decomposition,[15,25] hydrothermal synthesis,[26] microemulsion,[27,28] sonochemical 
synthesis,[29] and sonochemical synthetic route can all be directed to the synthesis of 
high quality of iron oxide nanoparticles. In addition, these magnetic nanoparticles can 
also be prepared by the other methods such as electrochemical synthesis,[30,31] laser 
pyrolysis techniques.[32] In table 1 are reported the main synthesis methods used to date 
for the preparation of magnetic nanoparticles and the nanoparticle characteristics. 
 
Table 1. Comparison of different synthesis methods to produce magnetic nanoparticles 
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Among these methodologies thermal decomposition and hydrothermal methods seems 
to lead to the best results in terms of fine particle size tuning and narrow particle size 
distribution. In order to obtain primary particles of appropriate size and with an 
adequate distribution of the same, these methods allow to control the kinetically phase 
nucleation and particle growth through the use of suitable stabilizing agents, often 
surfactants. Such stabilizers interact intimately with the surface of nanoparticles, so 
that the growth of the nanocrystals is kinetically inhibited by the capping of these 
chemical and physical agents.[33] The control of dimensions, of their distribution, 
morphology, degree of crystallinity, the agglomeration of particles during and after the 
synthesis and the manipulation of these materials, constitute critical points for 
obtaining the final product, given that from these parameters depend on the main 
properties of nanostructured materials. Recently, the method which has allowed to 
obtain precise control of size and shape of magnetic nanoparticles with a narrow size 
distribution, high crystallinity, high stability in organic solvents, is the synthesis based 
on the High Temperature Decomposition of organometallic precursors Assisted by 
Surfactants (HTDSA). [25]  
Iron oxide nanoparticles  with a high level of monodispersity and controlled 
size can be obtained by HTDSA of iron organic precursors, such as Fe(Cup)3, (cup=N-
nitrosophenylhydroxylamine), Fe(acac)3, (acac= acetylacetonate), or Fe(CO)5, using 
surfactants and high boiling point organic solvents such as the ones shown in table 2. 
 
Table 2. High boiling points solvents for thermal decomposition. 
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By rapidly increasing the reaction temperature to about 200 °C, triggering a burst of 
nucleation followed by aging at that temperature until the net nucleation rate is zero. 
Subsequently, the temperature is slowly increased to about the boiling temperature 
(about 300°C) of the solvent to promote particle growth by diffusion of free atoms to the 
growing particles.[34] Surfactants such as oleic acid, oleylamine, sodium oleate, and tri-n-
octylphosphine oxide (TOPO) are usually used as coordinating solvent in nucleation 
phase and growth of nanoparticles, and to avoid particle agglomeration during 
synthesis. The formation of an intermediate Fe–oleate complex is a critical step in 
determining the final particle size.[35,36]  
 
1.4 Biomedical applications of Magnetic Nanoparticles 
For many biomedical applications, magnetic nanoparticles presenting 
superparamagnetic behavior (no remanence along with a rapidly changing magnetic 
state) at room temperature are desirable. Biomedical applications are commonly divided 
into two major categories: in vivo and in vitro applications.  In vivo applications could be 
further separated in therapeutic (hyperthermia and drug-targeting) and diagnostic 
applications (nuclear magnetic resonance (NMR) imaging), while for in vitro 
applications the main use is in diagnostic (separation/selection, and 
magnetorelaxometry).[37] Consequently, additional restrictions apply on various 
magnetic nanoparticles for in vivo or in vitro biomedical application. It is rather simple for 
in vitro applications of magnetic nanoparticles. The size restriction as well as 
biocompatibility/toxicity are not so critical for in vitro applications, when compared 
with in vivo ones. Therefore, superparamagnetic composites containing submicron 
diamagnetic matrixes and superparamagnetic nanocrystals can be used. Composites 
with long sedimentation times in the absence of a magnetic field are also acceptable. It 
was noticed that functionalities may be provided readily for the superparamagnetic 
composites because of the diamagnetic matrixes. On the other hand, severe restrictions 
must be applied for magnetic nanoparticles for in vivo biomedical applications. First of 
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all, it is a requisite that the magnetic components should be biocompatible without any 
toxicity for the biosystems of interest. It is no doubt that interdisciplinary research 
collaboration is badly needed for clinical and biological applications of magnetic 
nanoparticles. Research fields involved include chemistry, materials science, cell 
engineering, clinical tests and other related scientific efforts.[38] In this section, an 
overview of the biomedical applications of magnetic nanoparticles will be presented.  
 
Figure 3. Magnetic Nanoparticles in Biomedicine. 
 
1.4.1 Therapeutic applications 
Hypertermia. The possibility of treating cancer by artificially induced hyperthermia has 
led to the development of many different devices designed to heat malignant cells while 
sparing surrounding healthy tissue. Experimental investigations of the application of 
magnetic materials for hyperthermia date back to 1957.[39] Since then there have been 
numerous publications describing a variety of schemes using different types of magnetic 
materials, different field strengths and frequencies and different methods of 
encapsulation and delivery of the particles. In broad terms, the procedure involves 
dispersing magnetic particles throughout the target tissue, and then applying an A.C. 
magnetic field of sufficient strength and frequency to cause the particles to heat. This 
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heat conducts into the immediately surrounding diseased tissue whereby, if the 
temperature can be maintained above the therapeutic threshold of 42°C for 30 min or 
more, the cancer is destroyed. The physical principle for which a magnetic material can 
be heated by the action of an external alternating magnetic field are the loss processes 
that occur during the reorientation of the magnetization of magnetic materials with low 
electrical conductivity.[40] Whereas the majority of hyperthermia devices are restricted 
in their utility because of unacceptable coincidental heating of healthy tissue, magnetic 
particle hyperthermia is appealing because it offers a way of ensuring only the intended 
target tissue is heated. The advantage of magnetic hyperthermia is that allows the 
heating to be restricted to the tumour area. Moreover, the use of subdomain magnetic 
particles (nanometre-sized) is preferred instead multidomain (micron-sized) particles 
because nanoparticles absorb much more power at tolerable AC magnetic fields.[41] 
Finally, it should be mentioned that the heating potential is strongly dependent on the 
particle size and shape, and thus having well-defined synthetic routes able to produce 
uniform particles is essential for a rigorous control in temperature. A number of studies 
have demonstrated the therapeutic efficacy of this form of treatment.[42] To date, 
however, there have been no reports of the successful application of this technology to 
the treatment of a human patient. The challenge lies in being able to deliver an adequate 
quantity of the magnetic particles to generate enough heat in the target using A.C. 
magnetic field conditions that are clinically acceptable. Most of the laboratory-based 
studies reported so far are characterised by the use of magnetic field conditions that 
could not be safely used with a human patient. In most instances, reducing the field 
strength or frequency to safer levels would almost certainly lead to such a reduction in 
the heat output from the magnetic material as to render it useless in this application. 
The frequency and strength of the externally applied A.C. magnetic field used to 
generate the heating is limited by deleterious physiological responses to high frequency 
magnetic fields. These include stimulation of peripheral and skeletal muscles, possible 
cardiac stimulation and arrhythmia, and non-specific inductive heating of tissue. 
Generally, the usable range of frequencies and amplitudes is considered to be f = 0.05-1.2 
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MHz and H = 0-15 kAm-1, and a common rule of thumb is that the product H− f should 
not exceed 4.85×108 Am-1s-1.[43] The amount of magnetic material required to produce the 
required temperatures depends to a large extent on the method of administration. For 
example, direct injection allows for substantially greater quantities of material to be 
localised in a tumour than do methods employing intravascular administration or 
antibody targeting, although the latter two may have other advantages. A reasonable 
assumption is that around 5-10 mg of magnetic material concentrated in each cm3 of 
tumour tissue is appropriate for magnetic hyperthermia in human patients.[5] 
Drug Delivery. The major disadvantage of most chemotherapies is that they are 
relatively non-specific. The therapeutic drugs are administered intravenously leading to 
general systemic distribution, resulting in deleterious side-effects as the drug attacks 
normal, healthy cells in addition to the target tumour cells. For example, the side effects 
of anti-inflammatory drugs on patients who have chronic arthritis can lead to the 
discontinuation of their use. However, if such treatments could be localised, e.g. to the 
site of a joint, then the continued use of these very potent and effective agents could be 
made possible. Recognition of this led researchers in the late 1970s to propose the use of 
magnetic carriers to target specific sites (generally cancerous tumours) within the body. 
The objectives are twofold: 
- to reduce the amount of systemic distribution of the cytotoxic drug, thus 
reducing the associated side-effects, 
- to reduce the dosage required by more efficient, localised targeting of the drug.  
In magnetically targeted therapy, a cytotoxic drug is attached to a biocompatible 
magnetic nanoparticle carrier. These drug/carrier complexes usually in the form of a 
biocompatible ferrofluid are injected into the patient via the circulatory system. When 
the particles have entered the bloodstream, external, high-gradient magnetic fields are 
used to concentrate the complex at a specific target site within the body ( figure 4).  
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Figure 4. A hypothetical magnetic drug delivery system shown in cross-section, a magnet is placed 
outside the body in order that its magnetic field gradient might capture magnetic carriers flowing in the 
circulatory system. 
 
Once the drug/carrier is concentrated at the target, the drug can be released either via 
enzymatic activity or changes in physiological conditions such as pH, osmolality, or 
temperature, and be taken up by the tumour cells.[5] The process of drug localization 
using magnetic delivery systems is based on the competition between forces exerted on 
the particles by blood compartment, and magnetic forces generated from the magnet, i.e. 
applied field. When the magnetic forces exceed the linear blood flow rates in arteries (10 
cm s-1) or capillaries (0.05 cm s-1), the magnetic particles are retained at the target site 
and maybe internalized by the endothelial cells of the target tissue.[44] This system, in 
theory, has major advantages over the normal, non-targeted methods of cytotoxic drug 
therapy. The physical principles underlying magnetic targeting therapy are similar to 
those used in magnetic separation, and are derived from the magnetic force exerted on a 
superparamagnetic nanoparticle by a magnetic field gradient. The effectiveness of the 
therapy is dependent on several physical parameters, including the field strength, 
gradient and volumetric and magnetic properties of the particles. As the carriers 
(ferrofluids) are normally administered intravenously or intra-arterially, hydrodynamic 
parameters such as blood flow rate, ferrofluid concentration, infusion route and 
circulation time also play a major role  as do physiological parameters such as tissue 
depth to the target site (i.e. distance from the magnetic field source), reversibility and 
strength of the drug/carrier binding, and tumour volume.[45] In general, larger particles 
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(e.g. magnetic microspheres, around 1 µm in diameter, comprising agglomerates of 
superparamagnetic particles) are more effective at withstanding flow dynamics within 
the circulatory system particularly in larger veins and arteries. 
Preliminary investigations of the hydrodynamics of drug targeting suggest that for most 
magnetite-based carriers, flux densities at the target site must be of the order of 0.2 T 
with field gradients of approximately 8 Tm-1 for femoral arteries and greater than 100 
Tm-1 for carotid arteries. This suggests that targeting is likely to be most effective in 
regions of slower blood flow, particularly if the target site is closer to the magnet source. 
As discussed above, there are several major advantages of using magnetic nanoparticles 
in drug delivery. First, drug bound magnetic nanoparticles can penetrate through small 
capillaries and be taken up by cells. Secondly, the movement of drug loaded magnetic 
nanoparticles can be readily controlled by an external magnetic field. Hence, 
accumulation of efficient drugs at the target sites can be achieved. Thirdly, 
biocompatible magnetic for example core–shell nanoparticles allow sustained drug 
release over a period of time. Fourthly, after being injected into bodies, the drug uptake 
process can be visualized by MRI. Finally, unlike searching for new molecules, magnetic 
drug delivery involves low-cost research, which reduces the cost of drug loaded product. 
Despite many merits, there are some problems associated with magnetic drug delivery. 
The major limitation of magnetic drug delivery systems is that the external magnetic 
field should be lowered to a certain level, higher than which living bodies cannot 
withstand. However, a magnetic field at this level may not generate magnetic gradient 
high enough to control the targeted movement of nanoparticles or trigger the drug 
desorption because the magnetic gradient decreases with the distance. This problem can 
be alleviated by locating an internal magnet near the target by minimally invasive 
surgery. Another problem which may occur in magnetic drug delivery is the possible 
agglomeration of magnetic nanoparticles, that may cause a tough embolization of the 
blood vessels in the treated area, especially after the removal of the applied magnetic 
field, due to their high surface energy.[46] Further, smaller nanoparticles possess weaker 
magnetic force. Thus, the ultrasmall dimension of nanoparticles, which is required for 
superparamagnetism, may lead to difficult control of their movement or location in the 
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presence of a relatively strong drag force from the blood flow. Consequently, magnetic 
drug delivery is more effectively controlled in blood flows with lower velocities. Further, 
when applying this technique to human bodies, a magnetic field with a safe strength 
may not be effective due to the large distance between the target site and the magnet. 
Pre-clinical and experimental investigations have been carried out to overcome these 
limitations and improve the efficiency of magnetic drug delivery at a safe level.[38] 
1.4.2 Diagnostic applications 
The diagnostic applications of magnetic nanoparticles are processes to detect malignant 
tissues or pathogenic bioaggregates by using magnetic nanoparticles. 
MRI contrast enhancement. In life science, an emerging technology, molecular 
imaging, has been playing a substantial role in both scientific investigation and practical 
bioapplications. Molecular imaging is the technology that helps us to understand 
diseases and search for the appropriate treatments. Since most disease processes have a 
molecular basis, molecular imaging with sufficient image resolution and image contrast 
at the molecular level is much needed for better diagnostic differentiations, early disease 
detection and objective therapy monitoring with imaging biomarkers.[47] There is a 
number of molecular imaging techniques available ranging from ultrasonic to gamma ray 
and X-ray frequencies in the electromagnetic spectrum. Molecular imaging operates at 
the interface between life science and physical science, and images are obtained by 
facilitating interaction with a biological entity at a molecular level. Thus, both the life 
and physical sciences are required to develop and implement a molecular imaging 
technique due to its diverse nature. Among them, optical imaging, nuclear imaging and 
magnetic resonance imaging (MRI) are the most widely used molecular imaging 
techniques. Magnetic nanoparticles are able to enhance the image contrast in MRI, 
which has attracted enormous attention. To better investigate the functions of magnetic 
nanoparticles as a contrast agent in MRI, it is necessary to first understand the working 
mechanism and physical principles in MRI. As far as the imaging mechanism of MRI is 
concerned, the technology is based on the detection of nuclear spin in molecules. When 
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the nuclei of protons are exposed to a strong magnetic field, their spins align either 
parallel or antiparallel to the magnetic field. During their alignment, the spins precess 
under a specified frequency, known as the Larmor frequency (ω0), (figure 5(a)). When a 
‘resonance’ frequency in the radio-frequency (RF) range is introduced to the nuclei, the 
protons absorb energy and are excited to the antiparallel state. After the disappearance 
of the RF pulse, the excited nuclei relax to their initial, lower-energy state (figure 5(b)). 
There are two different relaxation pathways. The first, called longitudinal or T1 
relaxation, involves the decreased net magnetization (Mz) recovering to the initial state 
(figure 5(c)). The second, called transverse or T2 relaxation, involves the induced 
magnetization on the perpendicular plane (Mxy) disappearing by the dephasing of the 
spins (figure 5(d)). Based on their relaxation processes, the contrast agents are classified 
as T1 and T2 contrast agents. Commercially available T1 contrast agents are usually 
paramagnetic complexes, while T2 contrast agents are based on iron oxide 
nanoparticles, which are the most representative nanoparticulate agents.[49] 
 
 
Figure 5. Principle of magnetic resonance imaging. (a) Spins align parallel or antiparallel to the magnetic 
field and precess under Lamor frequency (ω0). (b) After induction of RF pulse, magnetization of spins 
changes. Excited spins take relaxation process of (c) T1 relaxation and (d) T2 relaxation. 
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The reason for using magnetic nanoparticles in MRI is to shorten both T1 and T2* 
(shorter relaxation time) so that the image contrast can be enhanced. Iron oxide 
nanoparticles have been tested for contrast enhancement in MRI. Superparamagnetic 
nanoparticles are magnetically saturated in the common magnetic fields applied in MRI, 
and they are able to create a substantial locally perturbing dipolar field, and hence 
successfully decrease the value of T1 and T2*. To further improve biocompatibility, iron 
oxide-based superparamagnetic nanoparticles are always coated by a biocompatible  
layer such as Dextran, PEG, SiO2, DMSA, which can be excreted via the liver after 
treatment. In MRI, biofunctionalized magnetic nanoparticles are selectively taken up by 
the reticuloendothelial system, which serves as a network to remove foreign substances 
from the blood circulation system. It was found that magnetic nanoparticles with 
diameter less than 10 nm had a longer half-life than those of 30 nm in diameter or larger 
in the blood stream. Larger nanoparticles are recognized by liver and spleen, while 
smaller ones are collected by the reticuloendothelial system in healthy tissues 
throughout the body. It is the differential uptake of magnetic nanoparticles by different 
tissues that determines the MRI contrast. For tumor cells, the relaxation times are not 
changed by introducing contrast agent (magnetic nanoparticles) due to the absence of 
an effective reticuloendothelial system in the tumor. Therefore, identification of 
malignant lymph nodes, liver tumors and brain tumors by comparing the image contrast 
can be readily achieved in the presence of magnetic nanoparticles in MRI. It has been 
also noticed that iron oxide nanoparticles have the capability of being encapsulated into 
target-specific agents. Another type of common contrast agents T1 used in MRI is 
paramagnetic gadolinium ion complexes. Generally, magnetic labeling is employed by 
using fluorescent-labeled magnetic nanoparticles in both in vitro and in vivo imaging. 
The combination of nanoscale dimensions, superparamagnetic properties and 
fluorescence for these bifunctional nanoparticles has prompted their use in medical 
imaging which combines fluorescent imaging techniques and the MRI approach. Both 
methods are of great importance in diagnostic and therapeutic applications because 
cellular monitoring provides valuable information for subsequent cell-based therapy. 
The advantage of the MRI technique is well known: it offers anatomically sensitive deep 
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tissue imaging. As discussed above, magnetic resonance imaging is one of the most 
powerful medical tools for diagnostic purposes owing to its noninvasive process, high 
spatial resolution and multidimensional tomographic capabilities. However, this 
technique suffers from low-signal sensitivity. To overcome the weakness of current MRI 
techniques, signal enhancers need to be used. The signal-enhancing capabilities of 
magnetic nanoparticles/nanocrystals have been demonstrated. Magnetite (Fe3O4), as a 
member of clinically benign iron oxide-based nanoparticles, has been widely explored 
for signal-enhancing purposes.[38] 
Magnetic Separation and Purification. In modern biology or biomedicine, separation 
of particular biological entities (e.g. DNA, proteins, ions, molecules, etc.) from their 
native environment is often required for both scientific investigation and practical uses. 
Magnetically labeled biological entities exhibit magnetic properties so that they can be 
separated by applying an external magnetic field. Due to this reason, magnetic 
separation and purification have been widely used to prepare concentrated bio-samples 
in biomedical applications. A typical magnetic separation usually contains two steps: 
labeling desired biological entities with magnetic materials and separating magnetically 
tagged entities via a magnetic separation device. To ensure an effective labeling, 
functionalization needs to be performed to deposit biocompatible molecules on 
magnetic nanoparticles. The organic or inorganic coating not only provides a link 
between the particles and target biological entities, but improves the colloidal stability. 
A highly effective method of labelling cells is via antibody/antigen bonding due to its 
specific binding characteristics. By this technique, various biological entities (e.g. cancer 
cells, bacteria, red blood cells, Golgi vesicles, etc) have been demonstrated binding to 
immunospecific agents–coated magnetic nanoparticles. Similarly, magnetic 
microparticles can also be used for larger entities when incorporated in a polymer 
binder. In the second step of magnetic separation, when the mixture passes through a 
magnetic field, magnetic labeled targeted materials immobilize because of the force due 
to the magnetic field gradient and separate from the native solution. Due to the 
magnetic properties of magnetic-labeled biomolecules, magnetic separation may be 
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achieved by simply using a permanent magnet to aggregate magnetic entities on the wall 
of a test tube followed by removal of the supernatant. This simple process is illustrated 
in figure 6(a).  
 
Figure 6. Schematic of two standard methods for magnetic separation. (a) A magnet is placed close to the 
container wall of a solution containing magnetically tagged (•) and unwanted (◦) biomaterials. Due to 
the magnetic force exerted the tagged particles are attracted by the magnet and agglomerate while the 
unwanted biomaterials can be removed with the supernatant solution; (b) a solution containing tagged 
and unwanted biomaterials flows continuously through a region with strong magnetic field gradient 
which can be provided by packing the column with steel wool. Thus the tagged particles can be 
attracted. Afterwards, the tagged particles can be collected after removing the field followed by flushing 
through with water. 
 
However, this method is suffering from its low separation efficiency because of the slow 
accumulation rates. Thus better magnetic separation is needed. A common method of 
achieving high separation efficiency is to use a magnetizable matrix of wire or beads to 
apply a strong magnetic field on a flow column through which magnetically tagged fluid 
is pumped. The type of separator design is able to generate high magnetic field gradient 
and capture the magnetic biological entities efficiently as they flow with their carrier 
medium. Figure 6(b) depicts the schematic of this process. In spite of its faster 
separation, this method, however, has some problems caused by the settling and 
adsorption of magnetic materials on the matrix. To overcome this problem, an 
alternative separation design was developed, as shown in figure 7.  
(a) (b) 
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Figure 7. Schematic illustration of a rapid throughput method for magnetic separation. In this method, a 
solution containing magnetically tagged (•) and unwanted (◦) biomaterials flows through an annular 
column placed within a set of magnets arranged in quadrature. (a) Longitudinal cross-section view of the 
annular column showing the flow of the solution; (b) transverse cross-section view of the four magnets 
with the resulting magnetic field lines. Under the magnetic force due to the magnetic field gradient, the 
tagged particles are attracted to the column walls, where they are held until the field is removed. The 
held tagged biomolecules can be recovered by flushing the column with water. 
 
In this design, a magnetic gradient is created radially outwards from the center of the 
flow column by a quadrupolar arrangement. So obstruction will not take place during 
the separation. Additionally, biological entities with different magnetophoretic 
mobilities can be fractioned to achieve ‘fluid flow fractionation’ by adjusting the 
magnitude of the field gradient. In a typical separation process, the applied magnetic 
field is moved up the column while the fluid is kept static. Consequently, the particles 
can be moved up by the magnetic force and collected by a permanent magnet. The 
bottom section of fluid is then subjected to repeat separation processes with different 
magnetic strengths. Magnetic separation can be used with optical sensing to perform 
‘magnetic enzyme linked immunosorbent assays’. Immuno-assays, combined with 
fluorescent enzymes, are able to detect cells labeled by the enzymes. In contrast to a 
conventional means in which the target cells need to bind to a solid matrix, magnetic-
assisted immunosorbent assays utilize magnetic microspheres as the surface for cell 
immobilization. Importantly, magnetic separation is typically used to increase the 
concentration of the target materials. Recently, magnetic nanoparticles have been 
employed in this assay application. The use of nanoparticles improves the magnetic 
separation efficiency because their high mobility results in a short reaction time and 
(a) (b) 
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more immobilized reagent. Furthermore, magnetic separation offers an effective way to 
localize labeled cells at certain locations, which is of great help for cell detection and 
number counting by optical scanning.[3, 38] 
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 Chapter 2 
Magnetic Nanoparticles: 
Surface Modification and Silica Nanocomposite 
 
 
Superparamagnetic nanoparticles have been widely used for numerous in vitro and in vivo 
applications. All these biomediacal and bioengineering applications require that these nanoparticles 
need special surface coating of the magnetic nanoparticles, which has to be not only non-toxic and 
biocompatible but also allow a targetable delivery with particle localization in a specific area. This 
chapter focuses on the surface modification of the magnetic nanoparticles through organic and 
inorganic coatings. The type of specific coating depends on the end application and should be chosen 
by keeping a particular application in mind.  
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Chapter 2 
Magnetic Nanoparticles: 
Surface Modification and Silica Nanocomposite 
 
2.0 Surface modification of magnetic nanoparticles 
2.1 Introduction 
Superparamagnetic iron oxide nanoparticles with appropriate surface chemistry have 
been widely used experimentally in biomedical field. The biomedical and bioengineering 
applications require that these nanoparticles have high magnetization values and size 
smaller than 100 nm with overall narrow particle size distribution, so that the particles 
have uniform physical and chemical properties.[1] In addition to these applications, the 
development of methods aimed at the post-synthetic surface modification of magnetic 
nanoparticles is important to render them not only non-toxic, biocompatible, soluble in 
water, but chemically functional, and thus allow a targetable delivery with particle 
localization in a specific area. Several magnetic oxides have been synthesized using 
water-based methods like coprecipitation, oil in water microemulsions or micelles 
strategies, hydrothermal and sonochemistry processes.[2,3,4,5,6] The disadvantage of these 
aqueous solution syntheses is that the nanoparticle quality, more specifically their size 
and shape uniformity and in some cases crystallinity, is rather poor. About ten year ago, 
a new synthetic procedures have been developed to obtain scalable preparative routes 
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for high-quality magnetic nanoparticles,[7] that could be synthesized by thermal 
decomposition of different types of iron precursors such as iron acetylacetonate,[8,9] iron 
pentacarbonyl,[10] and iron-oleate,[11] in the presence of surfactants, such as oleic acid and 
oleylamine. The nanoparticles resulting from this procedure are stable in nonpolar 
solvents (such as hexane or cyclohexane) and capped with nonpolar end-groups on their 
surface. The capping molecules (also called ligands) are typically long-chain alkanes 
with polar groups that bind to the nanoparticles’ surface. Although the thermal 
decomposition method has the advantage of producing very monodisperse particles, it 
has the big disadvantage that the resulting nanoparticles are only dispersible in 
nonpolar solvents, which to some extent limits their applications in biological fields. 
Hence, to make ferrite magnetic nanoparticles suitable for biological applications, the 
hydrophobic surfactant coating needs to be replaced by a hydrophilic, biocompatible, 
and functional coating that allows controlled interaction with biological species. In 
literature recently lot of work has been made in this direction; hydrophobic magnetic 
nanoparticles have been coated with organic or inorganic systems. [9,12-14]  
2.2 Surface modification  
The colloidal stabilization of the magnetic nanoparticles in both aqueous and 
physiological medium is crucial for their therapeutic applications and can be achieved 
by either charging the surface or conjugating it by macromolecules for steric hindrance. 
The surface charge can be monitored and ensured by suitable means such as changing 
pH of the medium or modifying with functional groups. The steric stabilization can be 
achieved by attaching/grafting of organic small molecules, macromolecules, and 
inorganic coating on the surface. The steric stabilization is indeed less sensitive to the 
ionic strength of the suspension medium and can be easily achieved in both polar and 
non-polar medium. The oxide nanoparticles may be stabilized either during their 
synthesis or in a post-synthesis process. The in situ modification during synthesis 
process has several advantages including reduced agglomeration.[15] 
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2.2.1  Organic coating 
The binding affinity of large surfactant molecules or long polymer chains to the 
nanoparticles may be lost due steric hindrances, which could otherwise be easily 
overcome by using small molecules having multiple functional groups such as carboxyl 
(COOH), amine (NH2), thiol (SH), phosphate and sulfates. These stabilizers can be 
tailored for dispersibility into aqueous media or other biocompatible fluids. The 
presence of hydroxyl groups on the surface of oxide nanoparticles provides a versatile 
route for multiple functionalities. Furthermore, the presence of large number of 
functional groups on the surface of nanoparticles may be used for linkage of various 
biomolecules as well as drugs. Among various small molecules, citrate moiety having 
multiple carboxylate functionalities,[17] aminesilane for amine groups used as stabilizing 
agent,[18] and dimercaptosuccinic acid (DMSA), because having thiol functionality achieved 
great deal of attention due to their higher binding affinity towards metal and metal 
oxide nanoparticles.[19]  
Macromolecules. A variety of polymer molecules have been used for steric stabilization 
of oxide nanoparticles in aqueous and high ionic strength media.[20] The polymer shell 
improves the stability of nanoparticles in solution and allows the encapsulation of a 
therapeutic agent. Further, these stabilizers provide a means to tailor the surface 
properties of nanoparticles such as surface charge and chemical  functionality or their 
thermosensitive properties. Major facts with regard to polymeric stabilizer that may 
affect the performance of nanocarriers include the chemical nature of the polymer (i.e., 
hydrophilicity/hydrophobiciy, biocompatibility and biodegradation), the molecular 
weight of the polymer, the manner in which the polymer is grafted or attached (i.e., 
physically or chemically), the conformation of the polymer and the degree of particle 
surface coverage. Among various macromolecules, dextran has been widely used for 
surface modification mostly because of its favorable size (chain length) and 
biocompatibility, which enables optimum polar interactions (mainly chelation and 
hydrogen bonding). Dextran coating not only provides a smooth outline and narrow size 
distribution but also retains the essential superparamagnetic behavior of iron oxide 
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nanoparticles and a significantly prolonged the storage stability.[21] PEG is hydrophilic, 
water-soluble, biocompatible polymer and  extensively used to increase blood 
circulation times.[22] 
Other coating. The amphiphilic molecules such as liposomes have been successfully used 
to stabilize oxide nanoparticles for therapeutic application.[23] Liposomes have also the 
ability to encapsulate a  large number of nanoparticles and deliver them together to the 
specific target site. Both hydrophilic and hydrophobic foreign molecules such as drugs 
and biomolecules can be easily anchored to the amphiphilic liposomes which can 
enhance the multifunctionality of a system. 
 
2.2.2 Mechanisms of surface modification by organic molecules 
Ligand exchange. This  is a an alternative method for tuning the surface properties of 
nanoparticles. The concept of ligand exchange is very simple: mixing nanoparticles wit 
the free ligands results in replacement of outgoing ligands  with the incoming ones.[24] 
Exchanging weakly bound ligands for strongly binding ligands is to replace a strongly 
bound ligand with a ligand present in high concentration during the exchange 
procedure. This drives the equilibrium towards the thermodynamically less stable 
nanoparticles (NP) coated with weakly binding ligands; thus satisfying Le Chatellier’s 
principle:  
[ ][ ]
[ ][ ]nm
m
n
XXNP
YXNP
K −
−=  
where n and m are the number of molecules of X and Y respectively.[25] 
The position of this equilibrium depends on the properties of the incoming and outgoing 
ligand. If the ligands have similar structure, the equilibrium constant is close to 1.[26] For 
functionalized ligands, however, the situation becomes much more complicated. The 
true equilibrium may be difficult to achieve as there are some very slow processes on the 
nanoparticle surface which do not go to completion even after many days. These 
processes can disturb the apparent equilibrium position. The exact number of ligands 
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per nanoparticle is often unknown, and not all ligands can be exchanged; this makes 
accurate determination of the equilibrium constant difficult. Additionally, the position 
of equilibrium seems to depend on the exact ratio of incoming to outgoing ligands, 
presumably due to the different reactivity of different binding sites on the nanoparticles 
surface.[24] The main advantages of the method are the simplicity and the fact that the 
process not increase the size of the nanoparticles due to the small size of the exchange 
agents such as silanes,[27] tetramethylammonium hydroxide,[28] silsesquioxane,[29] 
carboxylic,[30] phosphonic,[31] mercaptoalkanoic acids,[32] and polymers.[25] However, this 
method relies on the exchange of the surfactant coating ligands with the substitutional 
molecule of which one end carrying a functional group that is reactive toward the 
nanocrystal surface and the other end carrying a hydrophilic group as carboxylic or 
sulfonic acid , that are found to stabilize the particles for longer time.[34]  Due to the 
relatively high prevalence of potential ligands in vivo, including thiols, carboxylic acids, 
peptides, sugars and phosphates; ligands on nanoparticles intended for in vivo use must 
have a high enough affinity for the nanoparticles that they will not undergo significant 
exchange with these species. The stability of ligand shells is governed by many of the 
same factors that stabilize self-assembled monolayers. Stability is dominated by the 
strength of the ligand-surface bond, but the ability of the ligand tails to pack in an 
ordered fashion is also significant. The structure and hence the stability of a ligand shell 
can be altered by the position of a single methyl group,[35] the presence or absence of a 
single unsaturated bond[36] or other packing factors such as chain length[37] and π-π 
stacking.[38] The concentration of free ligands available to form a monolayer also 
influences the ligand orientation and hence degree of stabilization afforded.[39] Light 
induced reactions at the nanocrystals/ligand interface can also often lead to desorption 
of the ligands.[25,40] In aqueous solution, the ligand-nanoparticle interaction is basically 
the same but a number of different effects important for stability arise. Most commonly, 
hydrophilic nanoparticles are stabilized by electrostatic repulsion by the equally 
charged ligand molecules on the particle surface. However, in the presence of high salt 
concentration the electric field is shielded and the nanoparticles can come close to each 
other until eventually attractive forces cause the particles to agglomerate, as induced 
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dipole interaction, Van-Der-Waals force, or hydrogen bonds.[41] Depending on the 
isoelectric point (pI) and the pH of the solution, nanoparticles can also lose or change 
the sign of their charge. 
In conclusion, ligand exchange in nanoparticles can be compared with ligand 
substitution reactions in metal complex,[25] but in reality the mechanism appears to be 
more complex. Indeed the  nanoparticles have a electronic structure very complex and 
hardly comparable with that of mononuclear complex, and on the success of ligand 
exchange process also depends on the shape, the size,  the polydispersity of 
nanoparticles size, and from their  high degree of packing and crystalline order.  
Intercalation. Another strategy used to convert hydrophobic nanoparticles in 
hydrophilic is to create a system of forces and hydrophobic interactions causes the 
hydrocarbon chains to intercalate, forming a new bilayers. In this way,  the ligand 
bilayer allows one to transfer hydrophobic particles from the organic solvents to 
aqueous phase. The molecules acting as phase-transfer agents have to be amphiphilic, 
comprise a hydrophobic and a hydrophilic part, commonly one or more aliphatic chains 
and a polar, often charged, end group. One common class of such surfactants for the 
transfer from organic to aqueous phase are quaternary ammonium salts in which four 
hydrocarbon chains are bound to a nitrogen atom that is thus positively charged, the 
counter ions usually being chloride or bromide. 
 
2.2.3 Inorganic coating 
 
Silica (SiO2), gold (Au)
[33] and silver (Ag) are extensively used for surface modification of 
the oxide nanoparticles which forms core–shell structures, and provides stability to the 
nanoparticles in solution and further help in binding various biological molecules and 
drugs to the surface of nanoparticles through suitable functional groups. There has been 
considerable interest in stabilizing oxide nanoparticles with noble metal shells such as 
Au and Ag. The magnetic oxide nanoparticles with metal coating can be effectively 
stabilized in corrosive biological conditions and can be readily functionalized through 
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the well-established metal-sulfur chemistry. The magnetic core–shell nanoparticles with 
tunable plasmonic properties have great potential for nanoparticle-based diagnostic and 
therapeutic applications.[42] 
The stabilization of oxide nanoparticles by silica can easily be achieved either by Stöber 
process or microemulsion method.[9,43]  
 
2.2.4 Silica coating 
 
Silica has been exploited as a coating material for magnetic nanoparticles for the 
following advantages: 
- synthesis as well as physical and chemical properties of colloidal silica are well 
documented; 
- is chemically stable in most solvents and can be exposed to high temperatures; 
- is highly stable in water;  
-  its surface is easly functionalizable; 
-  show low toxicity (size dependent); 
- provides protection against chemical degradation of the magnetic core and prevent the 
release of potentially toxic components of the core; 
- the thickness of the coating can be tuned; 
-the porosity as well as the order of the pores can be controlled. 
 
In particular, mesoporous materials are a promising candidate in many applications due 
to their extraordinary properties such as monodisperse and tunable pore size, high 
surface area and pore volume in an inert and biocompatible matrix having a surface that 
is easily modified. Combining mesoporous silica with magnetic nanoparticles produces a 
nanocomposite system that can be manipulated through the use of a magnetic field. The 
major advantage on the application of the composites for biomedical purposes is that 
they can show multiple properties integrated in the same material,  such as fluorescence, 
magnetism, cellular labelling, and/or therapeutic functions. These materials can be 
35 
 
moved quickly to specific target locations, in-vivo or in-vitro, and have a significant 
potential in drug delivery, medical diagnostics, and magnetic resonance imaging.[44]  
In cases where attempts have been made to embed magnetic centers into mesoporous 
silica nanoparticles, the synthesized materials suffer from insufficient magnetic contrast 
achieved due to the low mass percentage (<1%) of incorporated magnetic nanoparticles 
or destruction of the well-ordered, high surface area character of the silica structure. The 
resulting low magnetic response is due to the thick mesoporous silica shell[45] or the 
large size of the mesoporous silica nanoparticles[46] and suggests that a large dose (e.g. 
175 mg or 500 mg magnetic nanoparticles/kg) would have to be injected, for example, to 
perform in vivo magnetic resonance imaging (MRI).[47] To date, these shortcomings 
largely limit the practical use for in vivo biomedical applications. To realize the full 
potential of multifunctional magnetic mesoporous silica nanoparticles, a synthesis must 
be designed that produces small, easily dispersed, and well-ordered silica particles with 
higher mass percentage of incorporated magnetic centers.[48]  
Mesoporous silica can be also used as an ideal matrix to produce fluorescent particles 
that find a broad range of applications that involve tagging, tracing, and labeling.[45,49] A 
myriad of organic (dyes, pigments) and inorganic (dyes, pigments, quantum dots, 
luminescent nanoparticles) fluorescent materials have been developed. Fluorescence of 
colloidal particles is typically achieved by incorporating either inorganic or organic 
fluorescent materials into a matrix. Inorganic dyes are typically more stable against 
oxidation and photobleaching. However, their limited variety, relatively low quantum 
yields, and limited compatibility restrict their broad utilization. The large variety of 
organic dyes, their high quantum yields, their absence of blinking, their excellent 
aqueous stability, and their relatively low toxicity make them attractive for use in 
fluorescent particles. The main problem associated with organic dyes is their relatively 
fast photobleaching. Some dyes can interfere with some biological processes. Sealing 
organic dyes into a silica matrix seems to be one of most promising approaches because 
of the wide compatibility of silica with other-including biological-materials. Hence, it is 
plausible to expect straightforward functionalization of fluorescent silica particles with 
various sensing molecules to give the particles preference for adhering to specific 
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molecules or materials.[50] Recently, a novel synthesis of one-step self-assembly of 
mesoporous silica particles with encapsulated organic dyes was proposed.[51,52] It is a 
templated sol-gel self-assembly of mesoporous particles with fluorescent dye added in 
relatively large concentrations (up to 0.01M) to the synthesizing bath. The dye 
molecules are physically entrapped inside 2-4 nm diameter mesochannels during the 
synthesis. In some cases, physical encapsulation of the fluorescent dyes creates also a 
problem. For example, open pore particles cannot protect the dye[53] from leaking. 
Encapsulation within special mesoporous silica particles (origami-particles),[51,52] which 
have self-sealed cylindrical pores, shows virtually no leakage of the dyes out of the 
particles.[54] Another possibility is to seal the pores of the silica nanoparticles with an 
external coating layer of PEG,  which  further increases their stability in solution.[47] The 
combination of a magnetic and a fluorescent entity may provide a new two-in-one 
multifunctional nanomaterials with a broad range of potential applications. First of all, 
multi-modal magnetic-fluorescent assays would be very beneficial for in vitro and in 
vivo-bioimaging applications such as MRI and fluorescence microscopy. Second of all, 
these nanocomposites can be utilised as agents in nanomedicine. For example, one of 
their most promising applications is a bimodal anticancer therapy, encompassing 
photodynamic and hyperthermic capabilities. Fluorescent-magnetic nanocomposites 
can also serve as an all-in-one diagnostic and therapeutic tool, which could be used, for 
example, to visualise and simultaneously treat various diseases. Another exciting 
application of magnetic-fluorescent nanocomposites is in cell tracking, cytometry and 
magnetic separation, which could be easily controlled and monitored using fluorescent 
microscopy. Finally, these nanocomposites can be used as nano-blocks to build various 
nanoelectronic and photonic devices by applying an external magnetic field to 
manipulate or arrange the magnetic nanoparticles and using fluorescence confocal 
microscopy to visualise and control their positioning. Thus magnetic-fluorescent 
nanocomposites are very promising materials, but there are some challenges to overcome 
in their fabrication. One of the main obvious problems is the complexity in the 
preparation of these nanocomposites, which frequently involves a multi-step synthesis 
and many purification stages. Therefore, the production of magnetic-fluorescent 
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nanocomposites is quite technically and time demanding. A specific difficulty in the 
preparation of two-in-one magnetic fluorescent nanocomposites is the risk of quenching 
of the fluorophore on the surface of the particle by the magnetic core. In addition, if 
there are a number of fluorescent molecules attached to the surface of the particle they 
may act to quench each other. There are several reasons for choosing mesoporous silica 
as a coating for magnetic particles in the fabrication of fluorescent-magnetic 
nanocomposites. First of all, the mesoporous silica coating provides an effective barrier 
to quenching of any fluorophores by the magnetic cores. In fact quenching can be 
controlled by the thickness of the silica shell. Second of all, the mesoporous silica is 
relatively inert and optically transparent allowing incorporation of fluorescent dyes or 
QDs directly into the silica spheres.[55]Recently, the union of near-infrared fluorescent 
(NIRF) dyes with magnetic nanoparticles has received significant attention due to the 
deep penetration of NIRF light through tissues. The integration of NIRF detectability 
may allow for these magneto-optic nanocomposites to be used for both presurgical 
planning by MRI and intraoperative resection of malignant tissues by optical imaging. 
Since both MRI and optical signals come from the same nanocomposites, the MR image 
can serve as a roadmap to the fluorescently labeled tumor cells.[56]  
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Chapter 3 
Colloidal Magnetic Nanoparticles prepared by high temperature 
thermal decomposition of organometallic precursors assisted by 
surfactants (HTDSA)  
 
In this chapter colloidal nanoparticles of magnetite (Fe3O4) and cobalt ferrite (CoFe2O4) with 
narrow particle size distribution are obtained by high-temperature decomposition of 
organometallic precursors in the presence of oleic acid and oleylamine. Particle size and magnetic 
proprieties are tuned by varying reaction conditions or by seed-mediated growth.  The as-
synthetized nanoparticles have a cubic spinel structure and spherical morphology, as characterized 
by XRD, TEM, HRTEM. The presence of the capping agents that makes the particles hydrophobic is 
evidenced by FTIR and TGA analysis. The magnetic properties are size and chemical composition 
dependent as verified by SQUID measurements. 
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Chapter 3 
Colloidal Magnetic Nanoparticles prepared by high temperature 
thermal decomposition of organometallic precursors assisted by 
surfactants (HTDSA)  
 
3.0 Experimental 
 
3.1 Introduction 
Much progress has been made over the past ten years on the synthesis of monodisperse 
nanoparticles. Mechanistic studies have shown that monodisperse nanocrystals are 
produced when burst of nucleation that enables separation of the nucleation and growth 
processes is combined with the subsequent diffusion-controlled growth process through 
which the crystal size is determined. Among the several chemical methods proposed to 
synthesize uniform nanocrystals of metals and metal oxides  the thermal decomposition 
of metal–surfactant complexes seems the most promising.[1] In this synthesis the 
decomposition of organometallic precursors in the presence of surfactants leads to the 
formation of intermediates species that reacts forming small clusters, which successively 
growth results in nanoparticles. The growing process is mainly controlled by the 
binding strength of surfactant molecules on the surface of nanoparticles. The relative 
amounts of the starting reagents including organometallic compounds, surfactants, and 
solvents are the key parameters for controlling the size and morphology of 
nanoparticles. The reaction temperature as well as the time may also be crucial for the 
precise control of size and morphology. The obtaining of colloidal nanoparticles can be 
described in terms of a sequence of ideal steps of nucleation and growth, then can be 
distinct in main three phases: 
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- first  phase: the decomposition of organometallic precursor  (i.e. metal 
acetilacetonates, acetates or metalcarbonyles) produces reactive species that 
forms monomer complexes with surfactant molecules; 
- second phase: nucleation  process, where the assembling of the monomers form 
the crystals. In this process, the numbers of generated nucleus per unit of time 
follows an Arrhenius law; 
- third phase: the crystalline particles can growth through the addition of other 
units of monomer in solution or loose units due to dissolvation, depending on 
supersaturation condition of the solution and on the size of particles (the 
solubility depends on particle size). 
Thermal decomposition, nucleation and growth process of the nanoparticles are 
schematically shown in figure 1.  
 
 
 Figure 1. Schematic process of nucleation and growth of the nanoparticles. 
 
3.2 Nucleation and growth mechanism in HTDSA strategy 
The classic study by La Mer and Dinegar[2] has shown that the colloidal synthesis of 
monodisperse nanocrystals consisting of three components (precursors, organic 
surfactants and solvents) requires a single, temporally discrete nucleation event, 
followed by the slower, controlled growth on existing nuclei. The principal advantage of 
this method is that highly monodisperse nanoparticles are synthesized; the main 
disadvantage is that the synthesis is carried out in organic, non-polar solvents and the 
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particles are hydrophobic requiring a further phase transfer to make them hydrophilic. 
The required growth parameters can be achieved by the rapid addition of reagents 
(precursors) into a hot coordinating solvent containing surfactants (figure 2).  
 
Figure 2. La Mer mechanism for monodisperse colloidal nanoparticles. 
 
The temperature is kept high enough to decompose the reagents, transforming them into 
active atomic or molecular species (monomers) with concentration above the nucleation 
threshold. This supersaturation is relieved by a short burst nucleation of nanocrystals. 
Upon nucleation the concentration of monomers in solution drops below the critical 
concentration for nucleation; the existing nuclei then grow by the incorporation of 
additional monomers present in the solution. For crystalline nanocrystals to form in this 
thermolysis process, the constituent atoms should be able to rearrange, overcome 
thermal barriers, and anneal during the growth. Hence, the temperature for growth of 
the nanocrystals must be chosen to be high enough to promote this atomic 
rearrangement and annealing. However, nanocrystals melt[3] at substantially lower 
temperatures (reduction of the melting temperature, by a factor of 1/2, compared to the 
bulk, is often observed for nanocrystals 2–3 nm in diameter) which is driven by the fact 
that in the nanoscale the surface energy of the liquid phase is much smaller than the 
corresponding solid with crystallographic facets, edges or corners. Thus, inorganic 
colloidal nanocrystals can be grown at substantially lower temperatures where organic 
molecules such as surfactants are stable. For this synthesis to be effective, appropriate 
precursors such as organometallic compounds, that rapidly decompose to produce 
monomers, need to be identified. The best precursors are simple molecules (e.g., metal 
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carbonyls) with “leaving groups” (e.g., CO) that readily depart leaving behind the 
desired monomers. Another important parameter influencing crystal growth is the 
strength with which the surfactant molecules adhere to the surface of the growing 
crystal.[4] Surfactants are adsorbed and desorbed rapidly from the surface of nanocrystal 
allowing the addition of atoms to the crystal already existing. The adhesion should be 
strong enough to protect the crystals with a monolayer coating, on average, to prevent 
them from agglomeration but, locally, weak enough to allow the surfactant to exchange 
on and off the surface of the growing crystal.[5] The latter ensures that regions of the 
surface of the crystal are accessible for growth. Examples of such surfactants that 
“dynamically solvate” the new crystal include alkyl phosphine oxides, alkyl phosphinic 
acids, fatty acid and amines and some nitrogen containing aromatics. In addition, the 
surfactants form complexes with the reactive monomer species. The diffusion rate and 
stability of these complexes in solution, as well as the adhesion of the surfactants to the 
growing nanocrystal surface are both temperature dependent. Hence, choosing the right 
temperature is the key to controlling the growth of the nanocrystals. The variation in 
growth rate as a function of size, in literature  has been studied in detail.[6] For small 
sizes with very high surface energies, the crystals are unstable due to the large number of 
surface atoms and lead to negative growth. At large sizes, with small surface/volume 
ratios, the crystals are stable and grow. The critical size, where the crystals neither grow 
nor shrink, depends on the concentration of monomers, with high monomer 
concentrations forming smaller sizes. The peak in growth rate with size is simply an 
effect of the geometric factor (growth of larger crystals require the incorporation of 
many more atoms compared to smaller crystals). Moreover, if the monomer 
concentration is high, smaller crystals will grow more rapidly than larger ones. This 
leads to a spontaneous narrowing of the size distribution; a process called size-
distribution focusing[7] that has been well demonstrated in experiments.[8] In general, to 
obtain monodisperse nanocrystals, it is desirable to temporally separate the nucleation 
from the growth step and essentially, the nucleation must occur on a short time scale (as 
in the rapid injection of precursors). Alternatively,[9] such synthesis can also be 
accomplished by mixing the reagents at a temperature low enough to preclude any 
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reaction. Then the chemical reaction is accelerated by the increase in solution 
temperature at a controlled rate to achieve the required supersaturation, which is 
followed by the burst nucleation. Adjusting the reaction conditions, which include time, 
temperature and concentrations of surfactants and precursors, in a systematic way 
allows good control of the crystal structure[10] and nanocrystal size in the synthesis. In 
general, tailoring the ratio of the concentration of precursors to that of the surfactant 
controls the size since a high surfactant/precursor ratio favors the formation of a larger 
number of smaller nuclei and thus a smaller nanocrystal size. Alternatively, the particle 
size can also be controlled either by the binding strength or the steric bulkiness of the 
surfactant stabilizer. Short chain surfactants (e.g., tributylphosphines) allow faster 
growth resulting in bigger particles while bulkier ones (e.g., trioctylphosphines) slow 
the rate of materials being added to the nanocrystals leading to smaller size. Similarly, 
using a pair of surfactants, one e.g. carbossilic acid, like oleic acid, which binds tightly to 
the nanocrystal surface and hindering growth and the other, e.g., alkylphosphine or 
ammine, like TOPO or oleylamine, binding weakly and promoting growth, has also been 
shown to be an effective way to control size. Many such systems also exhibit a second 
growth phase called Oswald ripening[11] where the high surface energy of the small 
particles promote their dissolution and the materials are re-deposited on the larger 
nanocrystals. This also increases the size distribution. If the growth rate is further 
increased beyond this focusing regime, nanocrystals with a variety of anisotropic shapes 
(such as disks, rods, etc.) are formed.[12,13] Such kinetic control of shape[14] can be further 
facilitated using selective adhesion of surfactants.[15] The rate of adhesion of surfactants 
and their dynamic exchange rate in solution are different for different crystallographic 
faces of a faceted crystal. Organic molecules that preferentially adhere to specific 
crystallographic planes can be used to modify their relative growth rates when 
compared to the rest resulting in anisotropic shapes. In summary, the size and 
morphology of the nanoparticles can be controlled by controlling the reaction times, the 
residence time at the temperature of decomposition, but also the concentration and 
ratios of the reactants, nature of the solvent, metal precursors, complexing strength, but 
also through addition of seeds.[16] The adsorption of a surfactant onto the surface of  the 
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nanoparticle stabilizes the colloid solution for long time. However, this type of process 
must be improved to be suitable for industrial preparation, especially in terms of safety 
of the reactant and the high temperature required.[17] 
 
3.3 Synthesis of Spinel Ferrite Nanoparticles 
In literature, the thermal decomposition at high temperature of iron(III) acetylacetonate, 
Fe(acac)3, in the presence of 1.2 hexadecanediol, of oleic acid and oleylamine (as a 
mixture of surfactants) and phenyl ether  or benzyl ether  as dispersing solvents, has 
been reported as an effective method for the synthesis of monodisperse nanoparticles of 
maghemite (γ-Fe2O3) or magnetite (Fe3O4), depending on the experimental conditions. 
The same reaction with the addition of other acetylacetonates as Co(acac)2 or 
Mn(acac)2, leads to the formation of CoFe2O4 or MnFe2O4 nanoparticles with a narrow 
particle size distribution.[1,18]   
In this work, magnetite and cobalt ferrite nanoparticles were prepared by HTDSA 
method, using iron(III) acetylacetonate (Fe(acac)3, Janssen Chimica, 99%), cobalt(II) 
acetylacetonate (Co(acac)2, Janssen Chimica, 99%), 1.2 hexadecanediol (1,2-HD, Aldrich 
97%), oleic acid (OA, Aldrich, 90%), oleylammine (OM, Aldrich, <70%), phenyl ether  
(PE, Aldrich, 99%),  and benzyl ether (BE, Aldrich, 99%). 
Four cobalt ferrite samples of different sizes from about 5 to 11 nm (CoFe1, CoFe2, 
CoFe3, CoFe4)[18,19]  were synthetized by thermal decomposition using 1 mmol of 
Co(acac)2, 2 mmol of Fe(acac)3, 10 mmol of 1,2-HD, 6 mmol (CoFe1, CoFe2, CoFe3) or 7 
mmol (CoFe4) of OA, 6 mmol (CoFe1, CoFe2, CoFe3)  or 7 mmmol (CoFe4) of OM, and 
20 mL of phenyl ether (CoFe1) or benzyl ether (CoFe2, CoFe3, CoFe4). All the reagents 
were mixed into a three-neck, round-bottom flask and stirred magnetically at room 
temperature. Under reflux, the mixtures were heated gradually to 200 °C and kept at 
this temperature for 30, 60, and 120 min for CoFe1, CoFe2, and CoFe3/CoFe4 
respectively. The temperature was then increased rapidly up to 265 °C for CoFe1, and up 
to 295 °C for CoFe2, CoFe3 and CoFe4 samples and the mixtures were kept for 30 min, 
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CoFe1 and CoFe2, and 60 min, CoFe3 and CoFe4 at this temperature. During the 
process, the initial reddish-orange color of the solutions gradually changed to dark-
black, indicating the formation of the oleyl-cobalt ferrite nanoparticles. The black-
colored mixture was cooled to room temperature by removing the heat source. Ethanol 
(40 mL) was then added to destabilize the mixture and the black material was 
recovered via centrifugation. The black product was then dispersed in hexane, 
centrifuged to remove any undispersed residue, destabilized with ethanol, centrifuged 
once more and then redisperse in hexane, giving rise to a ferrofluid that retains its 
stability for several months. Before SQUID, FTIR and TGA characterization, in order to 
obtain a powder, the product was recovered once again by adding an excess of ethanol 
and centrifugation (4500 rpm, 15 min) and drying the wet material at 40 °C overnight. 
The scheme of the synthesis is shown in figure 3. 
 
Figure 3. Schematic representation of the synthesis of OA/OM-CoFe2O4 samples by HTDSA method.   
With a similar procedure in N2 atmosphere, Fe3O4 (MAG) nanoparticles with sizes from 
4 to 12 nm have been achieved. Samples of cobalt ferrite and of magnetite were prepared 
by a one step method, except for the MAG3 sample that was obtained by seed-mediated 
growth  method starting from MAG2. In this case, Fe(acac)3 (2 mmol), 1,2-hexadecanediol 
(10 mmol), benzyl ether (20 mL), oleic acid (2 mmol), and oleylamine (2 mmol) were 
mixed and magnetically stirred under a N2 flow. 84 mg of MAG2  sample dispersed in 
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hexane (4 mL) was added. The mixture was first heated up to 100 °C for 30 min to 
remove hexane, then to 200°C for 1 h. Under a blanket of nitrogen, the mixture was 
further heated to reflux (300°C) for 30 min. The black-colored mixture was cooled to 
room temperature by removing the heat source, and the same procedure described above 
was followed in order to recover and wash the product. In tables 1a and 1b, the key 
parameters. 
 Table 1a. Key Parameters of the Synthesis Procedure (a) and (b). 
 
Table 1b. 
 
 
 
 
 
 
 
 
3.3.1 CoFe2O4 nanoparticles: Characterization 
 
The X-ray diffraction patterns (figure 4) of all the CoFe2O4 samples in the 10−70° 2θ 
range, indicate the presence of a unique CoFe2O4 phase with a cubic spinel structure 
(PDF Card 22-1086). The broad reflections, indicating the formation of a nanophase, 
become gradually narrower going from CoFe1 to CoFe4, and as a consequence the 
Sample 
<DTEM> 
(nm) 
Fe(acac)3 
(mmol) 
Co(acac)2 
(mmol) 
1,2-HD 
(mmol) 
OA 
(mmol) 
OM 
(mmol) 
BE 
mL 
PE 
mL 
CoFe1 4.6 2 1 10 6 6 - 20 
CoFe2 6.5 2 1 10 6 6 20  
CoFe3 7.8 2 1 10 6 6 20  
CoFe4 11 2 1 10 7 7 20  
MAG1 4.4 2 - 10 6 6 - 20 
MAG2 6.6 2 - 10 6 6 20  
MAG3 7.3 2 - 10 2 2 20  
MAG4 12 2 - 10 7 7 20  
Sample Solvent Thermal step 
1 
Thermal step 
2 
CoFe1 Phenyl ether 30 min at 200°C 30 min at 265°C 
CoFe2 Benzyl ether 60 min  at 200°C 30 min at 295°C 
CoFe3 Benzyl ether 120 min at 200°C 60 min  at 295°C 
CoFe4 Benzyl ether 120 min at 200°C 60 min at 295°C 
MAG1 Phenyl ether 
 
30 min at 200°C 30 min at 265°C 
MAG2 Benzyl ether 120 min at 200°C 60 min at 295°C 
MAG3 Benzyl ether 60 min at 200°C 30 min at 295°C 
MAG4 Benzyl ether 120 min at 200°C 60 min at 295°C 
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calculated average coherent domain size increases from 5.0 to 8.3 nm (table 2). The 
calculated cell parameter is 8.39 Å for all the samples, equal, within the experimental 
error, to the theoretical value (8.391 Å). 
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Figure 4. XRD patterns of the CoFe1, CoFe2,  CoFe3 and CoFe4 samples. 
 
In all the CoFe2O4 samples nanoparticles self-assemble in hexagonal close-packed 
superlattice, due to the high degree of uniformity in diameter (figure 5(a)).[19] The 
presence of surfactants at the nanoparticle surface keeps them isolated from each other 
by a coating layer of about 2 nm. As an example, in figure 5 some TEM (a) and HRTEM 
(b,c) images for the samples CoFe3 and CoFe4 have been reported.  
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Figure 5. Bright field TEM images of CoFe3 sample at low magnification (a); at high magnification (b) 
High Resolution TEM of the sample CoFe4(c); particle size distribution of the CoFe samples extracted 
from TEM images (d). 
 
The high resolution image (figure 5 (b)) of the sample CoFe3 shows a well crystallized 
spheroidal nanoparticle, as indicated clearly by atomic lattice fringes. Similar images 
have been collected for the CoFe1 and CoFe2 samples. Differently from the other 
samples, CoFe4 often shows nanoparticles with a rough spheroidal shape and poor 
crystallinity (figure 5 (c)). 
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Table 2. Mean Particle Size from XRD and TEM Data. 
Sample <D>
*
XRD 
(nm) 
<D>†TEM 
(nm) 
σ 
(%) 
CoFe1 5.0 4.6 17 
CoFe2 6.3 6.5 13 
CoFe3 7.6 7.8 10 
CoFe4 8.3 11 15 
 
*<D>XRD has been calculated  on the [311] reflection using the Sherrer equation and the Warren correction; 
†<D>TEM has 
been calculated by particle size distribution on about 200 nanoparticles in different images using an Image software. 
The standard deviation σ, is calculated from the following equation: 
 
 
From particle size distributions, obtained by bright field mode micrographs (figure 5(d)), 
a mean particle size of 4.7, 6.5, 7.8 and 11 nm for CoFe1, CoFe2, CoFe3 and CoFe4 
samples respectively, have been evaluated (table 2). The good agreement between <D>XRD 
and <D>TEM for the samples CoFe1, CoFe2 and CoFe3 confirms the high degree of 
crystallinity of the particles. For the sample CoFe4, being the crystallite size (coherent 
domain) significatively lower than the particle size obtained by TEM, it can be supposed 
that the high content of surfactants, used during the synthesis, can influence the atomic 
rearrangement during the growth step inhibiting the crystallization process, as observed 
by HRTEM image reported in figure 5(c). A decrease of polydispersity is observed 
increasing particle size (table 2) going from CoFe1 to CoFe3, and this trend can be 
directly correlated with the synthesis parameters. In fact, in order to obtain different 
particle size, two different strategies can be applied. The first one involves the increase 
of the permanence time at 200 °C (30 min for CoFe1, 1h for CoFe2 and 2h for CoFe3); the 
trend of the CoFe series confirms the literature data that indicate as a better mono-
dispersion can be obtained increasing the time length of the first thermal step at 200 
°C.[1] The second strategy consists on the increasing of the surfactant amount: CoFe4 
sample has been prepared increasing the concentration of the surfactants (oleic acid and 
oleylamine) from 6 mmol to 7 mmol (see table 1a). In literature some authors have 
reported that the increase of the surfactant concentration induces a decrease on the 
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nanoparticles size, some others confirm our trend.[20,21] This result could be justified 
supposing that during the thermal decomposition of the metallorganic precursor 
(Me(acac)x), and the nucleation step (200°C) an intermediate metal complex ([Me-
(ole)x]y) can form and influence the size of the nuclei and the subsequent phase of 
growth of the nanoparticles, according to the following reaction: 
 
Me(acac)x + Oleic Acid-Oleylamine  [Me(ole)x]y + byproducts 
 
FTIR and Thermal analysis were performed in order to study the presence of the 
capping agent bound to the nanoparticle surface. As an example, in figure 6 is reported 
the FTIR spectra of  the CoFe4 sample and of the 1:1 mixture of the surfactants (OA-
OM). 
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Figure 6. FTIR spectra of the mixture of the surfactants (OA-OM) (a), and  CoFe4 sample (b). 
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The FTIR spectrum of the surfactant mixture reveals modes characteristic of the oleyl 
group:[22,23] the peaks at 2855 and 2930 cm-1 are due to the symmetric and asymmetric 
CH2 stretching modes, and the peak at 3006 cm
-1 is attributed to a cis –CH=CH– 
arrangement.[23] The peak at 1710 cm-1, which is typical of the ν(C=O) mode of the COOH 
group is very small. The asymmetric and symmetric stretching at 3370 cm-1 and 3294 cm-
1, as well as the scissoring modes at 1608 cm
-1  of the NH2  group are absent.  
The most obvious explanation for the almost complete absence of these peaks is that the 
mixture of oleic acid and oleylamine consists of an acid-base complex of –COO- and –
NH3
+ ions. This is further confirmed by the presence of modes associated with νa (COO-) 
and νs (COO-) modes  of the carboxylate group observed at 1554 and 1394 cm-1.[22] 
A shoulder is observed at 1620 cm-1, which can be attributed to the antisymmetric 
deformation of –NH3
+ group, considering that protonated amines display an 
antisymmetric deformation in the 1625-1560 cm-1 range and a symmetric deformation in 
the 1550-1505 cm-1 range.[24,25] The modes observed in spectrum in the frequency region 
below 1500 cm-1 arise from complex combinations of the ν C-C stretch, ν C-O stretches, 
CH2 deformations and other motions related to NH3
+, which are too complex to be 
assigned. In particular, the spectrum shows an intense peak at 720 cm-1 which is typical 
of the CH2 rocking modes. Comparison of the FTIR spectra of the  mixture OA-OM and 
CoFe4 sample gives several interesting information. The strong asymmetric νa(CH2) and  
symmetric νs(CH2) stretching bands at 2920 and 2850 cm-1 are known to be 
characteristic for the CH2 chains that are present in oleic acid.[26] The presence of oleic 
acid was further confirmed by CH3 stretching at 2955 cm
-1, and two carboxylate 
stretchings at 1550 and 1410 cm-1. These carboxylate stretchings confirm the 
observations made by other researchers[27,28] that oleic acid is chemisorbed onto the 
nanoparticles’ surface via its carboxylate group through a bidentate bond rather that a 
monodentate bond. The spectrum of CoFe4 nanoparticles also shows modes 
characteristic of the amine group: a large peak at׽3360 cm-1, which can be attributed to 
the stretching mode ν(N-H) of the NH2 group and a peak at 1603 cm-1 due to the NH2 
scissoring mode. The presence of these peaks would suggest the presence of oleylamine 
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even if the formation of –COO-–NH3
+ acid-base complex. The strong  band at 590 cm-1 is 
characteristic of the Me-O vibrations related to the ferrite nanoparticles. 
The TGA analysis of all the samples give information about the amount of surfactant 
bound to the nanoparticle surface. In figure 7 is reported,  as  an example, the 
thermogravimetric analysis of CoFe1: beside the slight weight loss up to 200°C, that can 
be attributed to the sorbed water,  a noticeable weight loss between 200 °C and about 
350°C, due to the total thermal decomposition of the hydrocarbon chain, can be 
evidenced. The percentage weight loss increases with decreasing size of the 
nanoparticles (larger surface area/volume ratio) from 28% for CoFe1 to 13% for CoFe4.  
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Figure 7. FTIR Thermal analysis for  the CoFe1 sample. 
 
Moreover, to verify the actual Fe and Co content, ICP-AES analysis has been performed 
using multiple standard additions method. In each sample, the ratio Fe to Co has been 
found higher than the theoretical value of 2.  Some differences have been also found 
between the sample prepared by phenyl ether (CoFe1) and those synthetized by 
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benzylether (CoFe2, CoFe3, CoFe4): the Fe/Co molar ratio for the CoFe1 sample is 3.6  
while for CoFe2, CoFe3 and CoFe4 is 3. These results can be due to the differences in 
iron(III) and cobalt(II) acetylacetonates thermal decomposition, [29] as can be evidenced 
by the thermal analysis reported in figure 8.  
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Figure 8. Thermal analysis for the Fe(acac)3 and Co(acac)2..  
 
Moreover, an increase of the growing temperature from about 260 °C (diphenyl ether) to 
about 300°C (dibenzyl ether) can justify the different Fe/Co values. However, the 
presence of oleylamine and 1,2-exadecandiol (reducing reagents) can also influence the 
growth mechanism of the nanoparticles. In fact, under reductive environment,  iron(III) 
ions can be partially reduced to iron(II) ions and therefore may compete with Co(II) 
ions in the growth process.[30]  
Three of the four samples have been submitted to magnetic measurements by SQUID. 
ZFC-FC curves exhibit a maximum, and the corresponding temperature (Tmax) is 
directly proportional to the average blocking temperature.[31] An irreversible magnetic 
behavior is observed below a given temperature (Tirr) that is related to the blocking of 
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the biggest particles. An irreversible magnetic behavior is observed below a given 
temperature (Tirr) that is related to the blocking of the biggest particles. The difference 
between Tmax and Tirr provides a qualitative measure of the magnetic anisotropy 
distribution, which is strictly connected with the size distribution in the absence of 
interparticle interactions.[32] With the increase of particle size, Tmax (table 3) increases 
and this can be mainly ascribed to increase of particles volume, even if the influence of 
interparticle interactions should be taken into account.  
 Table 3. Table with  TB, Tmax, Tirr values and difference between the two for each of the CoFe1, CoFe2 
and CoFe3 samples. 
 
 
 
As expected, Tirr follow the same trend of Tmax (figure 9(a)), indicating superparamagnetic 
behavior at room temperature for the CoFe1, CoFe2, and CoFe3 samples. 
 
Figure 9. ZFC (full symbols) and FC(empty symbols) magnetizations for CoFe1 (black), CoFe2 (red) and 
CoFe3 (blue) recorded with an applied field of 2.5 mT (a); Hysteresis loops at 5K of CoFe1 (black), 
CoFe2 (red) and CoFe3 (blue) (b). 
Sample <D>TEM 
(nm) 
σ 
% 
Tmax 
(K) 
Tirr 
(K) 
CoFe1 4.6 17 207(5) 247(5) 
CoFe2 6.5 13 224(4) 285(4) 
CoFe3 7.8 10 262(5) 283(2) 
 
 
CoFe1
CoFe2
CoFe3
(a) 
CoFe1
CoFe2
CoFe3
(b) 
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Field dependence of magnetization investigated a 300 K shows completely reversible 
behavior, (i.e. zero remanence magnetization and zero coercivity) confirming that all the 
samples are in superparamagnetic state. Conversely at 5 K, being the nanoparticles in 
the blocked state, all the samples show an hysteretic behavior (figure 9(b)). Saturation 
magnetization (Ms) and coercive field (Hc) are reported in table 4. 
 
Table 4. Table with  Ms, Mr/Ms and Hc values recorded to 5K, of the CoFe samples. 
 
Ms values are lower than the bulk one (~90 Am
2kg-1)[33] and they are almost independent 
from particles size in the investigated range. Coercivity values, from 1.29 T to 1.81 T, 
increase as the particle size increases, showing an unexpected behavior. In fact, entering 
the nanoscale, the surface component (Ks) plays the key role in regulating the magnetic 
anisotropy, and usually Hc increases with the decrease of particle size. However, it is 
well known that the interactions between molecules and surface atoms of nanoparticles 
can induce modification on surface anisotropy, leading to a decrease of Ks.
[34] In our 
sample the presence of the surfactant bound to the particle[18] reduces surface 
anisotropy; then the key role is played by the magnetocrystalline component, leading to 
the observed increase of coercivity with particle size. The high values of Mr/Ms suggest a 
tendency toward cubic anisotropy with the increase of particle size.[35] 
 
3.3.2 Fe3O4 nanoparticles: Characterization 
 
X-ray diffraction patterns of the magnetite samples (MAG series), shown in figure 10, 
evidence Bragg reflections ascribable to a unique cubic iron oxide phase with an average 
coherent domain that increases going from MAG1 to MAG4 (table 5). Unfortunately 
XRD data cannot discriminate between magnetite (PDF Card 19−0629) and maghemite 
Sample 
<D>TEM 
(nm) 
σ 
% 
Ms 
(A m2 Kg-1 ) Mr-Ms 
Hc 5K 
(T) 
CoFe1 4.6 17 70(2) 0.7     1.29(3) 
CoFe2 6.5 13 68(2) 0.8     1.71(2) 
CoFe3 7.8 10 67(2) 0.9     1.81(4) 
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(PDF card 25-1402) structure, therefore, although the black color of the sample should 
suggest the presence of magnetite, we cannot assert that the sample is made up of pure 
magnetite. The calculated cell parameter is always between 8.37 Å and 8.38 Å for all 
samples; this value is lower than the theoretical one for magnetite (8.40 Å) and higher 
than that for maghemite (8.34 Å), suggesting a partial oxidation of the Fe(II). 
Preliminary Mossbauer Spectroscopy measurements further confirm that the 
Fe(II)/Fe(III) molar ratio is never equal to the theoretical value (1/2). It is probable that 
the contact of the nanoparticles with the air during the time elapsed from their synthesis 
up to their characterization can induce an oxidation of Fe(II) to Fe(III), at least at the 
nanoparticle surface. 
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Figure 10. XRD patterns of MAG1, MAG2, MAG3, and MAG4 samples. 
 
Table 5. Table with  Mean Particle Size from XRD Pattern , Mean Particle Size from TEM Data 
Sample <D>
*
XRD 
(nm) 
<D>† TEM 
(nm) 
σ 
(%) 
MAG1 3.9 4.4 17 
MAG2 4.6 6.5 15 
MAG3 7.2 8.0 12 
MAG4 11 12 16 
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*<D>XRD has been determinated on the [311] reflection using Sherrer equation and the Warren correction; 
†<D>TEM has been 
calculated via particle size distribution on about 200 nanoparticles in different images using Image software. The 
standard deviationσ, is calculated from the following equation: 
TEM analysis of the Fe3O4 samples (MAG) confirms the versatility of the HTDSA 
procedure in tuning nanoparticles size. As in the case of CoFe series  the nanoparticles 
show a spherical morphology, and a self-assemble in hexagonal close-packed 
superlattice, due to their narrow particle size distribution and to the organic coating 
layer (figure 11). 
 
Figure 11. Bright field TEM images for MAG1 (a), MAG2 (b), and MAG3(c) samples; HRTEM image of a 
single Fe3O4 nanopaticle for MAG3 sample (d); Particle size distribution of all MAG samples(e). 
 
The high resolution image (figure 11(d))  shows that Fe3O4 nanoparticles, as in the case of 
CoFe2O4 samples, have a spheroidal  shape and are single crystallites, as indicated clearly 
by atomic lattice fringes. Particle size distributions for MAG samples have allowed to 
evaluate the mean diameter and the polidispersity (table 5). In this case the polidispersity 
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values are quite similar in all the sample, although as in the case of the CoFe, a slight 
higher value has been obtained for the sample prepared by using phenyl ether. 
The samples of magnetite as the cobalt ferrite series are subjected to TGA and FTIR 
analysis. It is observed also in this case the presence of the surfactants (oleic acid-
oleylamine) bound on the surface of the nanoparticle. The thermal treatment up to 
350°C allow to remove completely the surfactants and the weight loss is nanoparticle 
size dependent (19% for MAG4 and 49% for MAG1).  The higher percentage of 
surfactant present on the magnetite samples, respect to the cobalt ferrite ones, can be 
due to the different number of the washing cycles. 
Among the four samples MAG1, MAG2 and MAG3 have been selected for magnetic 
characterization. Temperature dependence of magnetization  has been investigated by 
ZFC-FC protocols. The analysis of the ZFC-FC curves (figure 12(a)), as expected, shows 
an increase of Tmax and of the interparticle interactions by increasing the average size of 
nanoparticles. Values of the Tmax, and Tirr obtained  are reported in table 6. 
 
Figure 12. ZFC (full symbols) and FC(empty symbols) magnetizations for MAG1 (black), MAG2 (blue) 
and MAG3 (green) recorded with an applied field of 2.5 mT (a); Hysteresis loops at 5K of MAG1 (black), 
MAG2 (blue) and MAG3 (green)(b). 
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Table 6. Table with  TB, Tmax, Tirr values and difference between the two for each of the samples.  
 
Field dependence of magnetization investigated a 300 K shows completely reversible 
behavior, confirming that all the samples are in superparamagnetic state. Conversely at 5 
K, being the nanoparticles in the blocked state, all the samples show an hysteretic 
behavior (figure 12(b)). Saturation magnetization (Ms) and coercive field (Hc) are 
reported in table 7.  
 
Table 7. Table with  Ms, Mr/Ms and Hc values of the magnetite samples.  
 
 
 
 
 
Ms values are similar for all the samples but widely lower than that of the corresponding 
bulk magnetite (82 A m2 K g-1) and maghemite (92 A m2 K g-1).[36] In any case these values 
are comparable to those obtained in the literature for samples with similar size and 
prepared with similar method.[33] Some authors reports that the bulk values can be 
reached just with samples with particles size of at least 150 nm.[37] Coercivity values are 
in all cases very small if compared with CoFe samples. In particular, MAG1 and MAG2 
show a equal Hc value; this behavior can be caused by the reduced size of these two 
samples and to the similar average coherent domain (3.9 nm for MAG1 and 4.6 for 
MAG2). In these cases the surface anisotropy contribution of to the total anisotropy is 
very high. When the particle size further increases, the component of 
magnetocrystalline anisotropy prevails over that surface. 
Sample 
<DTEM> 
(nm) 
σ 
(%) 
Tmax 
(K) 
Tirr 
(K) 
Tirr-Tmax 
(K) 
MAG1 4.4 17 16.9(3) 100(20) 80(20) 
MAG2 6.5 15 20.3(8) 200(30) 180(30) 
MAG3 8.0 12 53(2) 200(20) 150(30) 
Sample 
<DTEM> 
(nm) 
σ 
(%) 
Ms 
(A m2 Kg-1 ) Mr-Ms 
Hc 5K 
(mT) 
MAG1 4.4 17 48.2(6) 0.068(2) 6.7(1) 
MAG2 6.5 15 54.1(2) 0.10(3) 7(3) 
MAG3 8.0 12 50.8(1) 0.39(4) 30(6) 
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In order to study the effect of chemical composition on magnetic properties, magnetite 
(MAG1) and cobalt ferrite (CoFe1) nanoparticles with similar particle diameter, 
prepared by HTDSA method, have been selected. Despite similar mean particle size, 
temperature dependences of magnetization measured by ZFC and FC protocol have 
completely different features. In particular, the temperature corresponding to the 
maximum in ZFC curve has a strong increase in cobalt ferrite sample (table 8), indicating 
an increasing of ∆EaαKV. 
 
Table 8. Mean particles from TEM dat (<D>TEM); Temperature corresponding to the maxium in ZFC 
curve (Tmax), coercive field (Hc) recorded at 5K. 
 
 
 
 
For spherical particles with similar size, ∆Ea increasing can be only ascribed to a strong 
increase of anisotropy (K). This picture is confirmed by field dependence of 
magnetization at 5 K (figure 13(d)), showing an hysteretic behavior with coercive field 
value (i.e. the magnetic field to which corresponds a magnetization equal to 0). 
 
Sample 
<D> TEM  
(nm) 
σ 
(%) 
Tmax 
(K) 
Hc 5K 
(T) 
CoFe1 4.6 17 207(5) 1.29(3) 
MAG1 4.4 17 16.9(3) 6.7(1) mT 
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Figure 13. Bright field TEM images of CoFe2O4 nanoparticles (CoFe1) (a); Bright field TEM images of 
Fe3O4 nanoparticles (MAG1) (b); ZFC (full symbols) and FC (empty symbols) magnetizations for CoFe1 
(black); and MAG1 (blue) recorded with an applied field of 2.5 mT (c); Hysteresis loops at 5 K for CoFe1 
(black) and MAG1 (blue). 
 
The high coercivity observed in the CoFe2O4 sample can be associated to the strong 
magnetocrystalline contribution of Co2+ ions (3d7), which have a non-zero orbital 
momentum.[38] 
 
3.4 Conclusions 
 
Exploring, understanding and exploiting the complex behavior in magnetic materials at 
nanoscale is the key and the challenge not only for fundamental research, but it is crucial 
for biomedical applications. Spinel ferrites are an ideal magnetic system to understand 
and govern magnetic properties through size tuning and chemical manipulations due to 
the strong sensitivity of their properties to the cationic distribution. The selected 
synthetic strategy has allowed to obtain nanoparticles with tunable size, high 
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crystallinity and a narrow particle size distribution. Temperature, time and amount of 
surfactants are the key parameters in order to modify the nucleation and growth 
kinetics and therefore the size of the particles.  The molecular coating, keeping the 
nanoparticles isolated from each other, ensures the achievement of weak-interacting 
systems. 
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Chapter 4 
Transferring of hydrophobic nanoparticles into water: 
 Ligand exchange and Intercalation processes 
 
 
In this chapter oleic acid-oleylamine hydrophobic nanoparticles are converted in hydrophilic 
systems by ligand exchange and intercalation processes. Hydrophobic nanoparticles obtained by 
high temperature surfactant assisted approaches show high crystallinity, narrow size distribution 
and tunable particle size but cannot be use directly for biological purposes, therefore it is necessary 
to transform them into aqueous dispersible systems. With this aim several molecules like succinic 
acid, dimercaptosuccinic acid, carboxylic acid-silane and poly[ethylene glycol]-silane, are used to 
be exchanged with the  capping agents of the nanoparticles. Cetytiltrimetil ammonium bromide are 
also employed because can intercalate oleic-acid and oleylamine molecules bound at the 
nanoparticle surface and makes the nanoparticles hydrophilic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
73 
 
 
Chapter 4 
Transferring of hydrophobic nanoparticles into water: 
 Ligand exchange and Intercalation processes 
 
4.0 Experimental 
 
4.1 Introduction  
 
The literature has a wealth of evidence showing that long chain carboxylic acids and 
amines, used as ligands during the synthesis, control the nucleation and growth kinetic, 
stabilize the nanoparticles and preventing agglomeration. Among the different 
carboxylic acids the most common are oleic,[1] lauric,[2] acids, while the most common 
ammine are oleylamine, octylamine and trioctylphosphine oxide (TOPO).  These ligands 
being  long chain molecules (C>12) with one polar group, are not soluble in water, thus 
to gain water solubility they has to be substituted with other molecules with further 
functional groups that allow the transferring to water. Alternately an intercalation 
process can be employed by using  molecules that interact with the apolar carbon chain. 
 
4.2 Ligand Exchange with carboxylic acid and alkylsilane 
 
In the present work ligand exchange  is performed on oleic acid/oleylamine capped 
cobalt ferrite nanoparticles (see chapter 3) by using two different dicarbossilic acid with 
short chain (C4) and two different alkylsilane: 
 
- Dimercaptosuccinic acid (DMSA); 
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- Succinic acid (SA);  
 
- n-(trimethoxysilylpropyl)ethylene diamine triacetic acid (carboxylic acid-
silane, Si_CA); 
 
- 2-[methoxy-(polyethyleneoxy)propyl] trimethoxysilane (poly[ethylene 
glycol]-silane, Si_PEG) 
 
 
 
 
Figure 1. Schematic illustration of the conversion of oleic acid/oleylamine capped-nanoparticles into     
hydrophilic systems by exchange ligand process. 
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4.2.1 Ligand Exchange with short chain carboxylic acids  
 
Hydrophobic cobalt ferrite nanoparticles of 11 nm in size (CoFe4) are transformed into 
hydrophilic by a ligand exchange reaction using meso-2,3-dimercaptosuccinic acid 
(DMSA, Aldrich, 98%), or  succinic acid (SA, Aldrich, ≥99.4%), dimethyl sulfoxide, 
DMSO (Fluka AG. Buchs SG, ≥99%), and toluene (Riedel-de Haen, ≥99.7%).  
Succinic acid and dimercaptosuccinic acid (DMSA), (figure 2) have been chosen for the 
following reasons: 
- they  tend to be hydrophilic due to their polarity and ability to form hydrogen 
bonds; 
- they can easily replace the oleic acid bound on the surface of nanoparticles; 
- they have free ligand groups for further biomolecule conjugations. 
 
 
Figure 2. Butanedioic acid (Succinic acid, SA) (a) 2,3-bis(sulfanyl)butanedioic acid (Meso 2,3-
dimercaptosuccinic acid, DMSA )(b). 
 
 
In a typical synthesis, in a glass flask, a magnetic nanoparticles dispersion (5.5 mg of 
nanoparticles in 3.5 mL of toluene, 6.7 mM), is added to the bifunctional molecule 
solution in DMSO (12.6 mg of DMSA  in 0.7 mL of DMSO or 8.15 mg SA in 0.7 mL,  98.6 
mM ), sonicated for 5 minutes and  mechanically stirred for 24 hours. After 24 hours the 
complete exchange process can be verified through an evident sedimentation of the 
black powder on the bottom of the flask and the transparency of the supernatant 
solution (figure 3(b)). To remove free surfactant molecules, the precipitate was recovered 
(a) (b) 
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by centrifugation, and washed several times with a 1:1 mixture of acetone and ethanol. 
The wet powder was than dispersed in 10 mL of water. The colloidal dispersion shows a 
pH value of about 6 and results to be opalescent dark brown. To favor the deprotonation 
of the carboxylic groups and the formation of a negative charge at the nanoparticle 
surface the pH is slightly increased up to 7.5-8 by the adding of NaOH  1M. The 
dispersion changes color from opalescent-brown to brown-transparent and retain its 
stability for a long time. (figure 3(d)).  
 
Figure 3. Colloidal dispersion before (a)  and after (b) ligand exchange process. Hydrophobic CoFe2O4 
nanoparticles capped with oleic acid/oleylamine dispersed in cycloexane (c), hydrophilic CoFe2O4 
nanoparticles capped with DMSA molecules dispersed in water (CoFe_DMSA). 
 
4.2.2  Characterization 
 
Figure 4 shows TEM images of CoFe4 sample in Bright Field  mode, before and after 
surface modification via ligand exchange by dimercaptosuccinic acid (CoFe4_DMSA) or 
by succinic acid (CoFe4_SA). Bright field image of CoFe4 sample (figure 4(a) and (b)) 
shows nanoparticles of cobalt ferrite of 11 nm in size with nearly spherical morphology. 
As already observed, the presence of the organic coating allow the self-assembling of the 
nanoparticles in hexagonal close-packed superlattice. After ligand exchange with DMSA 
(a) (b) 
(c) (d) 
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(figure 4(d), and (e)), as expected, the mean nanoparticles distance among the particles 
decreases significatively. A similar result is observed in the case of succinic acid-coated 
nanoparticles (figure 4(g) and (h)), even if an higher degree of aggregation than in the 
case of DMSA can be evidenced. To verify whether the nanoparticles, once coated with 
dicarbossilic molecules, have undergone size modifications, due to  possible phenomena 
of dissolution of metal in the presence of carboxylic acid, particle size distributions have 
been determined after one month from the exchange ligand process (figure 4(c), (f), (i)). 
The nanoparticle mean size doesn’t change, within the limit of the experimental error, 
after ligand exchange process and an ageing time of one month (table 1). 
 
Figure 4. TEM images in Bright Field mode of hydrophobic CoFe2O4 nanoparticles and particles size 
distribution histograms, before (a,b,c), and after ligand exchange with DMSA (CoFe4_DMSA (d,e,f)) and 
SA (CoFe4_SA (g,h,i)). 
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Table 1.  Average size (<D>TEM) and polydispersity (σ) of CoFe2O4 nanoparticles before and after ligand 
exchange process by DMSA and SA. 
Sample 
<D>TEM 
(nm) 
σ 
(%) 
CoFe4 11 15 
CoFe4_DMSA 11 14 
CoFe4_SA 11 15 
 
To verify the efficiency of the exchange ligand process FTIR spectra on CoFe4 and 
CoFe4-DMSA (figure 5) or CoFe4-SA (figure 6) samples are performed and compared 
with the DMSA or SA molecule FTIR spectrum.  
 
Figure 5. FTIR spectra of CoFe4, CoFe4_DMSA samples and pure DMSA (a), inset detail of peak at 2560 
cm-1 of the free SH group (b).  
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The spectrum of pure DMSA (figure 5) reveals a series of adsorptions typical for 
carboxylic acids that can be schematized as following:  
- the bands at 2970, 2830, 1420 cm-1 due to the OH stretching modes; 
- the adsorptions at 1280, 920 cm-1 associated to the OH bending modes; 
- the peak at 1200 cm-1 attributed to the C-OH stretching mode; 
 - the peak at 1700 cm-1 tipical of the  ν(C=O) mode of the free carbonyl stretching.  
Other interesting bands are associated to free thiol groups:   
- the  peak at 2560 cm-1 due to S-H stretching mode; 
- the bands at 1140 and 1000 cm-1 derived from the S-CH rocking modes.  
The spectrum of the oleic acid-oleylamine capped-cobalt ferrite nanoparticles (CoFe4) 
shows besides the peak at 590 cm-1, ascribed to the Me-O modes in the ferrite 
nanoparticles, two main peaks at 1550 and 1410 cm-1 associated with νa(COO-) and 
νs(COO-) of the carboxylate group, suggesting the presence of bidentate carboxylate 
bonded to the nanoparticle surface.[3]  
The vibrational modes characteristic of the amine group are also present even if they are 
very weak: a large peak at׽3360 cm-1, which can be attributed to the stretching mode 
ν(N-H) of the NH2 group and a shoulder at about 1600 cm-1 due to the NH2 scissoring 
mode. The adsorptions at 2920 and 2850 cm-1 typical for hydrocarbon chain are  due to 
the symmetric and asymmetric stretching of CH2 group.
[4]  
The comparison of the FTIR spectrum of the sample before and after exchange ligand 
process gives several interesting information.  
Besides the Me-O stretching mode associated to cobalt ferrite phase, a band at 1730 cm-1  
of the free carbonyl stretching and the small peak associated to free thiol groups at 2560 
cm-1 (see figure 5(b)) indicate the DMSA molecular coating of the nanoparticles.  In any 
case, the presence of some other bands due to the symmetric and asymmetric 
carboxylate stretching and to the sharp methylene peaks of the oleyl chain suggests that 
some oleic acid residuals is retained on the surface of CoFe2O4 nanoparticles. These data 
suggest oleic acid and oleylamine have been only partially exchanged with DMSA. 
Similar results have been obtained for succinic acid-capped nanoparticles (CoFe4_SA) 
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(figure 6) indicating a partial substitution of the original capping agent with succinic 
acid.  
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Figure 6. FTIR spectra of the pure Succinic Acid (SA),  CoFe4,  CoFe4_DMSA and  CoFe4_SA samples. 
 
In order to study the stability over time, the colloidal suspensions at pH-7-7.5  has been 
kept under visual observation. The CoFe4_DMSA dispersion is visibly stable up to 2 
month after which start to sediment. On the contrary CoFe4_SA suspension start to 
sediment just only after a week. It has been taken into account that these observations 
give information about macroscopic phenomena, therefore to better study the stability 
over time of the colloidal dispersions from a microscopic point of view it should be 
necessary to perform further characterizations like the dynamic light scattering in order 
to measure the hydrodynamic diameter.   
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The different behavior of the colloidal dispersions CoFe4_DMSA and CoFe4_SA at 
different pH values can be explain considering the DMSA and SA molecules. These 
molecules are a both small and have a good capacity to complex metallic ions by using 
one or two of their carboxylic groups.[5]  When nanoparticles are dispersed in water at 
pH 6-7, both suspensions are unstable because both carboxylic groups can be bonded to 
the nanoparticles surface. In figure 7, as an example, is shown the DMSA molecule in such 
conformation. No free COOH groups to make the suspensions stable are then present. 
However, if the  nanoparticles are dispersed in alkaline water (7.5-8), a spontaneous 
process can occur and one of the two carboxylic groups linked to the nanoparticle 
surface will become free. Under these conditions, the carboxylic groups (COOH) 
transformed into carboxylates (COO-) and will provide enough negative charge to 
stabilize the colloidal suspension via electrostatic repulsion. These systems with free 
carboxylate groups as such can be used as MRI contrast agent, in hyperthermia,  for 
magnetic separation and purification and also for conjugating with biological 
molecules.[6]   
 
Figure 7. Possible configuration of the DMSA molecules surrounding the magnetic nanoparticles at 
solution pH of 6-7 (a) and of 7-8 (b). 
 
The observation that at slightly alkaline pH the CoFe4_DMSA dispersion is more stable 
over time than the CoFe4_SA one can be justified with the further possibility of the 
(b) 
(a) 
DMSA 
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DMSA to form intermolecular disulfide cross-linking between the molecules (figure 8). It 
is well known in fact, that disulfides can be create by oxidation of the thiol groups in 
presence of oxygen in aqueous alkaline environment.[7] The reactions of oxygen with 
thiol compounds in aqueous solutions are most often described by equations 
2 RSH + O2 RSSR + H2O2 
4 RSH + O2  2 RSSR + H2O 
according to which the reactions gave disulfides and hydrogen peroxide or water.[8] 
However, it is known that oxidation of thiol compounds can afford products containing 
the S atom in different oxidation states depending on the reaction conditions. In any 
case, under mild conditions (pH 7-9), thiol compounds  are oxidized by oxygen to 
disulfides,[9] and only when the pH reach a value of 12, these compounds are transformed 
predominantly into sulfinic (RSO2H) and sulfonic (RSO3H) acids.
[10]  
 
 
Figure 8. Schematic illustration of meso 2,3- dimercaptosuccinic acid (DMSA)- coated magnetic 
nanoparticles. 
 
DMSA 
Cross-linking via 
disulfide bridge 
Reactive groups 
for bio-conjugation 
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The remaining DMSA free S-H groups can be used to attach target-specific 
biomolecules, as for instance antibodies for labeling cancer cells or for MRI cancer 
diagnosis. Using  the infrared spectroscopy the band absorption of thiol groups is not 
evident, which makes difficult the thiol detection.[6] In contrast, Raman spectroscopy is 
an excellent tool to detect the thiol group in molecules due to its enhanced Raman 
scattering. However, detection of thiol groups grafted onto iron oxide nanoparticles 
using Raman spectroscopy is quite difficult due to the strong absorption of the incident 
light by the dark cobalt ferrite nanoparticles, leading to very weak Raman scattering 
from DMSA molecules adsorbed at the nanoparticle’s surface. Moreover, by using a 
visible laser excitation source, the intense emission band of the spinel ferrite 
nanoparticles hides the thiol characteristic Raman band. To solve this problem, in the 
literature is proposed  the use of  both photoacoustic spectroscopy and Raman 
spectroscopy to monitor thiol groups (S-H) and the associated disulfide bridges (S-S), 
the latter resulting from the oxidation of the former.[11] 
 
  
4.3  Ligand Exchange with alkylsilane 
 
Most ligands reported in literature contain a carboxylate (COO-),[12] a phosphate (PO3
2-
),[13] or an alcohol (OH)[14]  endgroup to chemically adsorb to the nanoparticle surface 
and form a protective coating. It has been noted that the binding of these ligands is 
noncovalent, which means that they can be more easily desorbed from the surface,[12] 
which strongly affects the long-term stability of the nanoparticles, Furthermore, these 
ligands have only been reported with a limited variety of endgroups, thereby restricting 
their versatility and applicability. To meet this demand, a more robust and general route 
for decorating ferrite nanoparticles with diverse functionalities has to be developed. 
Lately, polymeric grafting is becoming increasingly popular as a way to tune the surface 
properties of nanoparticles.[15] However, these methods often rely on several subsequent 
steps, thereby making the process more complicated and harder to control. Therefore, 
inspired by the effectiveness and simplicity of silanes self-assembly on metal oxides, they 
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have been increasingly used to prepare silica-based composites of silane-functionalized 
nanoparticles.[16] However, all of these works have mainly focused on the silanization of 
hydrophilic nanoparticles, made via water-based methods.[17] Recently alkylsilanes have 
been proposed also to exchange the hydrophobic ligands on ferrite nanoparticles 
synthesized via the thermal decomposition method[18] to render these nanoparticles 
stable and dispersible in water. Silanes can fulfill high requirements, because they are 
known to form a densely packed thin film, which is covalently linked to the surface.[19] 
At the same time, they exhibit the major advantage that they are commercially available 
bearing a huge variety of functional endgroups. 
From a surface chemistry point of view, ferrites act similarly as metal oxides, presenting 
a high number of reactive surface hydroxyl groups.[20] Then ligand exchange is performed 
by substituting the weak bond with oleic acid/oleylamine with a stronger covalent one 
between the functional alkylsilanes and the nanoparticles’ surface hydroxyl groups 
(figure 9). 
 
Figure 9. Exchange of oleic acid ligands by silanes on the cobalt ferrite nanoparticle surface. 
 
Silanes are molecules with the general chemical formula Y-(CH2)n-Si-R3, where Y 
represents the headgroup functionality, (CH2)n an alkane chain, and Si-R3 the anchor 
group by which the silane will be grafted to the metal oxide surface (with R being Cl or 
OR′). Figure 10 gives an overview of silanes containing different endgroups and alkane 
chain lengths that can be used to perform the ligand exchange.  
The characteristics of the deposited silane layer on the particles’ surface strongly depend 
on reaction variables such as the type of solvent, the reaction time, the presence of a 
catalyst, the type of anchor group, and the silane concentration. 
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Figure 10. Different silanes bearing a wide variety of endgroups that can be bond on the nanoparticles 
metal oxide surface. 
 
The ways in which these parameters influence the surface modification process are 
generally known to be complicated and various.[19] The situation is even more 
complicated in the case of nanoparticles in which particle aggregation and interparticle 
crosslinking can occur.[16] Moreover, the homogeneity and extent of the silane ligand 
exchange may be crucial for the final performance of the magnetic nanoparticles. A first 
important observation regarding the silane ligand exchange procedure concerns the type 
of anchor groups. If chlorosilanes are applied, the nanoparticles are found to disintegrate 
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immediately because of the liberation of HCl, which is known to dissolve ferrite 
materials.  Therefore, only (m)ethoxysilanes can be used. 
 
4.3.1 Ligand exchange with alkylsilanes 
 
Hydrophobic ferrite nanoparticles (CoFe4) have been converted in hydrophilic using 
also n-(trimethoxysilylpropyl)ethylene diamine triacetic acid trisodium salt (Si-CA, 
ABCR GmbH & Co.KG,45% in water) or 2-[methoxy-(polyethyleneoxy)propyl] 
trimethoxysilane (Si-PEG, ABCR GmbH & Co.KG, 90%) and acetic acid (Aldrich, 
≥99.7%). 
 
 
Figure 11. Carboxylic acid-silane, Si-CA (a), and poly[ethylene glycol]-silane, Si-PEG (b) molecular 
formula. 
 
Acetic acid is added to catalyze the reaction and as a reagent for the hydrolysis and 
condensation of the alkoxysilane groups. The rate of condensation is determined by the 
anchor group and by the solvent used.[21] In the case in which a nonpolar solvent (hexane 
or cyclohexane) and an alkoxysilane are used, the condensation rates are known to be 
rather slow.[16] Therefore, the reaction is performed for long time (e.g., 72 hours) to 
ensure full exchange of the hydrophobic ligands and to promote a higher density of 
functional groups on the nanoparticles’ surface.[18] 
In a glass container under ambient conditions, 0.5 % (v/v) carboxylic acid-silane (Si-CA) 
or poly[ethylene glycol]-silane (Si-PEG) solution was added to 5 mL of a dispersion of 
(a) 
CH3 
(               )6-9 
(b) 
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hydrophobic CoFe2O4 nanoparticles in cyclohexane (2.6 mg cobalt ferrite/mL 
cycloesane), containing 0.01% (v/v) acetic acid. The mixture was mechanically stirred 
for 96 hours, in order to ensure the complete exchange between the hydrophobic 
surfactants and silane molecules, during which the particles tend to settle  on the 
bottom of the flask (figure 12). 
 
 
 
Figure 12. Colloidal dispersion after the ligand exchange with carboxylic acid-silane. 
 
The black-brown powder was separated using a magnet and washed several times by 
centrifugation with cyclohexane to remove all silane excess. The product was finally 
redispersed in 10 mL water.  
 
4.3.2  Characterization 
 
Figure 13 shows TEM images of cobalt ferrite nanoparticles in Bright Field mode, before 
(CoFe4) and after surface modification via ligand exchange by carboxylic acid-silane 
(CoFe4_Si-CA) or by  poly[ethylene glycol]-silane (CoFe4_Si-PEG). 
The hydrophobic nanoparticles modified with carboxylic acid-silane (figure 13(d), (e)) 
and with poly[ethylene glycol]-silane (figure 13(g), (h)) show a slightly higher degree of 
aggregation if compared with CoFe4 sample. Silane monolayer around the nanoparticles 
cannot be easily evidenced by TEM analysis due to both the thin thickness and the low 
contrast. 
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Figure 13. TEM images in Bright Field mode of hydrophobic CoFe2O4 nanoparticles and particles size 
distribution histograms, before (a,b,c), and after ligand exchange with Si-CA (CoFe4_Si-CA) (d,e,f)) and 
Si-PEG (CoFe4_Si-PEG (g,h,i)). 
 
Therefore, particle size distributions don’t show any significant change, within the limit 
of the experimental error, after exchange ligand process (figure 13 (c), (f), (i)) suggesting 
that a thin homogeneous layer of alckylsinane covers the nanoparticles. 
To verify the successful silane ligand exchange the FTIR spectroscopy has been used 
once again. FTIR spectra (figure 14) show CoFe2O4 nanoparticles before (CoFe4) and 
after ligand exchange process with carboxylic acid-silane (CoFe4_Si-CA) and  
poly[ethylene glycol]-silane (CoFe4_Si-PEG).  
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Figure 14. FTIR spectra of the CoFe4, CoFe4_Si-CA and CoFe4_Si-PEG samples. 
 
The most clear evidence of the exchange is that the strong band 590 cm-1, characteristic 
of the Me-O vibrations related to the ferrite nanoparticle, after ligand exchange, 
undergoes a broadening and a shift at 600 cm-1;  this behavior can be due to the 
formation of Me-O-Si bonds.[22] Furthermore, compared to the as synthesized oleic 
acid/oleylamine stabilized nanoparticles, several new bands are observed between 1000 
and 1150 cm-1. These bands are characteristic of silane layers and are originated from Si-
O-Si vibrations.[23] The alkane chain present in both silanes, as well as in the oleyl chain, 
results in the appearance of typical bands at 2920 and 2850 cm-1, attributed to 
asymmetric and symmetric CH2 stretchings respectively. The position and width the of 
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these CH2 bands is known to give more information about the crystalline packing of the 
alkane chains in the silane layer.[24] The observed values (2920-2850 cm-1) and the 
broadening of the bands implicate that the silane layers deposited on the ferrite 
nanoparticles do not exhibit an ordered packing. This low degree of order could be 
attributed to partial condensation between the Si-OH or Si-OR caused by the high 
radius of curvature of the nanoparticles or to the partial presence of the starting capping 
agent.  Notable, is the appearance of a small band at ~2960  cm-1 in the case of carboxylic 
acid-silane (CoFe4_Si-CA). This band is ascribed to the symmetric CH3 stretching of the 
alkoxy anchor group and gives proof of an incomplete hydrolysis of the silane molecules 
during ligand exchange. The complete disappearance of the carboxylate stretchings at 
1550 and 1410 cm-1 associated at the oleic acid, after ligand exchange with the carboxylic 
acid-silane (CoFe4_Si-CA), unfortunately cannot be observed, as they are overshadowed 
by the broadening of the asymmetric (1620-1580 cm-1), symmetric (1380 cm-1) COO- 
stretchings, and of the band at 1410 cm-1 of the bending CH2-COO
- group, related to the 
three carboxylate groups of the carboxylic acid-silane.  
The presence of Si-PEG at the surface cobalt ferrite nanoparticles (CoFe4_Si-PEG)  is 
confirmed by its characteristic ethylene glycol vibrations. The broadening of the bands 
in the 2800-3000 cm-1 region is the result of strong overlapping of the CH2 stretchings 
(asymmetric and symmetric) in the PEG-tail and in the alkane chain. The symmetric 
CH2 stretching is found at 2920 and 2850 cm
-1, respectively. The bands at 1470, 1420, 
1380, 1290, 1200 cm-1 correspond well with the CH2-O-CH2 scissoring, wagging 
(gauche), wagging (trans), twisting, and stretching, modes, respectively. PEG is known 
to exhibit different conformations such as amorphous, helical crystalline, and all-trans 
crystalline, dependent on its chain length and density.[25] On the basis of the literature 
data, we can suppose that the PEG-silane coating  on the nanoparticles  is mainly 
present as amorphous state.[26] The stability of the aqueous dispersions of  CoFe4_Si-CA 
and CoFe4_Si-PEG have been studied up to three months. As can be seen from the 
images shown in figure 15, the colloidal suspensions in water of  CoFe_Si-CA (figure 15(a)) 
and CoFe_Si-PEG (figure 15(b)), are stable up to 2 month. 
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Figure 15. Stability in water of CoFe_Si-CA (a), and CoFe_Si-PEG (b) samples. 
 
4.4 Intercalation process with CTAB (MAG_CTAB)  
Cetyltrimethylammonium bromide (CTAB) is a cation surfactant containing a 
quaternary ammonium group (their hydrophilic head), and a hydrocarbon chain (their 
hydrophobic tails). When dispersed in water it forms spherical micelles above the 
critical micellar concentration (CMC of 0.87 mM at 25°C) in which the hydrophilic head 
group forms the outer surface and the hydrophobic tails point towards the centre.[28] 
(figure 16). 
 
Figure 16. Cationic surfactant cetyltrimethylammonium bromide (CTAB); CMC= 0.87 mM at 25°C. 
 
By the use of this cationic surfactant hydrophobic magnetite nanoparticles  of 6 nm in 
size (sample MAG2, see chapter 3) are transformed into hydrophilic by an intercalation 
process (figure 17).  
 
(a) (b) 
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Figure 17. Intercalation process of hydrophobic Fe3O4 nanoparticles with CTAB. 
 
The sample MAG2 has been converted  in hydrophilic dispersing 4.9 mL of ferrofluid (1.1 
mg Fe3O4/ml in chloroform), (figure 18(a)) in a aqueous solution containing 0.2 g of CTAB 
in 10 mL of water (0.55 mmol). A vigorous stirring  for 1 hour followed by the heating at 
60 °C for 30 minutes generate a stable and clear aqueous dispersion of magnetic 
nanoparticles (figure 18(b)). In the first step, when the hydrophobic capped magnetic 
nanoparticles stable in organic solvent (chloroform) are added into a CTAB aqueous 
solution, the CTAB molecules intercalate the capping agent stabilizing the magnetic oil 
droplets leading to the formation of an oil-in-water microemulsion.[27] Subsequent 
evaporation of the volatile organic solvent by mild heating drives CTAB molecules to 
directly interact with the magnetic nanoparticles surface ligands through hydrophobic 
interactions. The alkyl chains of the CTAB and the magnetic nanoparticles surface  
ligands intercalate into each other, rendering the CTAB cationic headgroup (quaternary 
amine) facing outward and the magnetic nanoparticles-CTAB complex water-
soluble.[28,29] 
 
93 
 
 
Figure 18. Hydrophobic Fe3O4 nanoparticles capped with oleic acid/oleylamine (MAG2) (a), and 
hydrophilic  Fe3O4 nanoparticles after intercalation by CTAB molecules (MAG_CTAB) (b). 
 
 
4.4.1  Characterization 
 
TEM images in Bright Field mode (figure 19(a)), before and after the intercalation, show 
that no evident modification occur, being the mean interparticle distance similar.  
 
Figure 19. TEM images of  Fe3O4 sample in Bright Field mode, before (a) and after  phase transfer using 
CTAB (b). 
 
When the hydrocarbon tails of CTAB interpose between the hydrocarbon tails of oleic 
acid /oleylammine, no evident modification occur. (figure 19(b)) TEM bright field images 
show that the morphology as well as the  mean interparticle distance is retained after 
intercalation, probably because the CTAB (C16) has a similar length hydrocarbon chain 
(C16) to the oleic acid/oleylammine. 
 
25 nm 
(b) 
25 nm 
(a) 
(b) (a) 
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Figure 20. FTIR spectra of CTAB, MAG2 and MAG_CTAB samples. 
 
The FTIR spectrum of MAG2_CTAB sample, after intercalation process, (figure 20) 
exhibits, beside the main peak of Fe-O mode centered at 590 cm-1, a series of adsorptions 
attributable to the presence of CTAB:  
-the bands at 2920, 2850 cm-1 and  1450 cm-1, are  identified as symmetric, asymmetric 
stretching, and bending CH2 modes; 
-the peak at 3010 cm-1 is due to the N-CH3 mode; 
- at 960, 900 cm-1 are centered the adsorption of C-C stretching modes.  
The presence of oleic acid molecules bonded to the nanoparticle surface is confirmed by 
the peak at  1550 cm-1, associated with νa(COO-) of the carboxylate group.[3]  
The MAG2_CTAB sample is stable over time for months. The system as such, could be 
used in the biomedical field.  
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4.5 Conclusions 
In order to successfully prepare and biofunctionalise nanoparticles for a given 
biomedical application, a wide range of physical, chemical, biological and physiological 
factors and conditions must be taken into account. Surface modification of hydrophobic 
nanoparticles can be carried out by different approaches, among which we selected 
exchange ligand and intercalation processes.  The exchange ligand process is one of the 
most versatile ways to convert an hydrophobic nanoparticle into an hydrophilic system, 
to add new functionalities and tune the minimum distance between the particles and 
therefore the magnetic inter-particles interaction. The intercalation process can be also 
used to convert hydrophobic nanoparticles into hydrophilic system. All these systems, 
are stable in water and can be employed in MRI and hyperthermia applications.  
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Chapter 5 
Colloidal Magnetic Mesostructured Silica Nanoparticles 
  
 
 
In this chapter the synthesis and the microstructure of a series of ordered Mesoporous Silica 
Nanoparticles (MSN) and Magnetic Mesoporous Silica Nanoparticles (MMSN) are illustrated.  
With the aim of finding the suitable material to meet biological needs, some parameter of the 
synthesis  (concentration of precursors, type of surfactant, time, concentration of magnetic 
nanoparticles) are modified so that different porous structures (hexagonal and cubic), different size 
and different compositions are obtained. The combined use of X ray diffraction at low and wide 
angle, Transmission Electron Microscopy, N2-physisorption and Fourier Transformer Infrared 
Spectroscopy allowed to evidence the interesting  features of the nanosystems. Magnetic properties 
are also studied in the case of the magnetic composites. 
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Chapter 5 
Colloidal Magnetic Mesostructured Silica Nanoparticles 
 
5.0 Experimental 
 
 5.1 Introduction 
For many years, silica has been employed as a versatile and relatively benign material in 
material sciences and engineering due to the variety of available chemical and physical 
modifications that it offers as well as the biocompatibility.[1] With the rapid advance of 
nanoscience over the past decades, nanosized porous amorphous silica has been 
investigated intensively and used in a wide variety of applications including catalytic 
supports, chromatography, sensor technology, and gas storage. The first mesoporous 
molecular sieves of the M41S family were developed by researchers at Mobil 
Corporation in 1992. These materials exhibit narrow pore size distributions, similar to 
those found for zeolites. Whereas the pore sizes of zeolites are typically less than 10 Å, 
the pores of the M41S materials can be tailored between 15 and more than 100 Å.[2] This 
class of materials is characterized by very large specific surface areas, ordered pore 
systems, and well-defined pore radius distribution. The M41S materials can be obtained 
in different compositions, either as pure silica or as aluminosilicate. The M41S family has 
several well-known members like MCM-41 (Mobil Composition of Matter No. 41), 
MCM-48 and MCM-50. A unique feature of these materials is that although they are all 
composed of amorphous silica, they have a long-range ordered framework with uniform 
mesopores. The structure of MCM-41 (hexagonal phase, space group p6mm) consists of a 
hexagonal packing of one-dimensional channels with a pore diameter ranging between 
20 and 100 Å. MCM-48 (cubic Ia3d structure) has a bicontinuous structure, which 
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consists of two independent and intricately interwoven networks of mesoporous 
channels, while MCM-50 has a laminar structure (space group p2) (figure 1). [3,4]  
 
Figure 1. Structures of mesoporous M41S materials: a) MCM-41 (2D hexagonal, space group p6mm), b) 
MCM-48 (cubic, space group Ia3d), and c) MCM-50 (lamellar, space group p2). 
 
A mesoporous material related to the M41S family is SBA-15 (Santa Barbara Amorphous 
No. 15). SBA-15 is a hexagonal silica with a larger pore size than MCM-41 (from 89 to 
more than 300 Å) and thicker silica cell walls. The use of supramolecular aggregates of 
ionic surfactants (long-chain alkyltrimethylammonium halides) as structure-directing 
agents (SDAs) was groundbreaking in the synthesis of these materials. These SDAs, in 
the form of a lyotropic liquid-crystalline phase, lead to the assembly of an ordered 
mesostructured composite during the hydrolysis and condensation of the silica 
precursors under basic conditions. The mesoporous materials are obtained by 
subsequent removal of the surfactant by extraction or calcination. In-depth 
investigations into the formation process of these composite materials have found that 
two different mechanisms are involved: on one hand, in true liquid-crystal templating 
(TLCT), the concentration of the surfactant is so high that under the prevailing 
conditions (temperature, pH) a lyotropic liquid-crystalline phase is formed without 
requiring the presence of the precursor inorganic framework materials (normally 
tetraethyl-(TEOS) or tetramethylorthosilicate (TMOS)).[5] On the other hand, it is also 
possible that this phase forms even at lower concentrations of surfactant molecules, for 
example, when there is cooperative self-assembly of the SDA and the already added 
inorganic species, in which case a liquid-crystal phase with hexagonal, cubic, or laminar 
arrangement can develop (figure 2).[6,7] 
(c) (b) (a) 
102 
 
 
Figure 2. Formation of mesoporous materials by structure-directing agents: a) true liquid-crystal 
template mechanism, b) cooperative liquid-crystal template mechanism. 
 
 In the meantime, the original approach has been extended by a number of variations, for 
example, by the use of triblock copolymer templates (Pluronic 123)  under acidic 
conditions by which means the so-called SBA silica phases may be synthesized. A 
fundamental condition for this method is that an attractive interaction between the 
template and the silica precursor is produced to ensure inclusion of the structure 
director without phase separation taking place. Figure 3 illustrates the different 
interactions that can take place between the inorganic components and the head groups 
of the surfactants. These interactions are classified as follows: if the reaction takes place 
under basic conditions (whereby the silica species are present as anions) and cationic 
quaternary ammonium surfactants are used as the SDA, the synthetic pathway is termed 
S+I- (figure 3(a); S: surfactant; I: inorganic species). The preparation can also take place 
under acidic conditions (below the isoelectric point of the SiOH-bearing inorganic 
species; pH~2), whereby the silica species are positively charged. To produce an 
interaction with the cationic surfactant, it is necessary to add a mediator ion X- (usually 
a halide) (S+X-I+; pathway (b)). Conversely, when negatively charged surfactants (e.g., 
long-chain alkyl phosphates) are used as the SDA, it is possible to work in basic media, 
whereby again a mediator ion M+ must be added to ensure interaction between the 
equally negatively charged silica species (S-M+I-; pathway (c)); a mediator ion is not 
required in acidic media (S-I+; pathway (d)). Thus, the dominating interactions in 
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pathways (a-d) are of electrostatic nature. Moreover, it is still possible for the attractive 
interactions to be mediated through hydrogen bonds. This is the case when nonionic 
surfactants are used (e.g., S0 : a long-chained amine; N0 : polyethylene oxide), whereby 
uncharged silica species (S0I0 ; pathway (e)) or ion pairs (S0(XI)0 ; pathway (f)) can be 
present.  
 
Figure 3. Interactions between the inorganic species and the head group of the surfactant with 
consideration of the possible synthetic pathway in acidic, basic, or neutral media. Electrostatic: S+I-, S+X-
I+, S-M+I-, S-I+; through hydrogen bonds: S0I0/N0I0, S0(XI )0. 
 
 
The syntheses of ordered mesoporous solids described above are classified as 
endotemplate methods (“soft-matter templating”). In exotemplate methods 
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(“nanocasting”), a porous solid is used as the template in place of the surfactant. Thus, 
this method is also known as “hard-matter templating”. The hollow spaces that provide 
the exotemplate framework are filled with an inorganic precursor, which is then 
transformed (cured) under suitable conditions. In this way, the pore system of the 
template is copied as a “negative image”. After removal of the now-filled exotemplate 
framework, the incorporated material is obtained with a large specific surface area (figure 
4).[8]  
 
Figure 4. Examples of nanosystems obtained by the method nanocasting. 
 
In fact, silica mesostructured nanoparticles show, besides to the  typical features for 
mesostructured materials, ideal size (up to 100-150 nm) for across the biological 
membranes making them excellent candidates for imaging, labeling, and therapeutic 
when associated with magnetic or fluorescent nanoparticles or molecules.[9] 
Furthermore, the reduced size and the low density allow to obtain them stable in water 
in colloidal form. 
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5.2 Mesoporous Silica Nanoparticles  
 
To date, there have been great efforts made in the development of synthetic approaches 
for the preparation of mesoporous nanoparticles with narrow particle size distribution. 
Recent studies have shown that their tendency to aggregate in specific physiological 
conditions, or sizes greater than 150 nm, limit their use in the biomedical field. In fact 
mesoporous nanoparticles with diameters greater than 100 nm are rapidly taken up by 
the reticuloendothelial system (RES),  accumulating in the liver and spleen before a 
loaded drug can be delivered to the target cells/tissue,[10] but that smaller silica NPs (<50 
nm diameter) with poly(ethylene glycol) (PEG) modification have significantly 
decreased uptake by RES organs and exhibit a longer blood circulation time. Although 
well-ordered mesoporous  nanoparticles  with diameters as low as 20 nm have been 
synthesized using a double surfactant system, the resulting nanoparticles aggregate 
easily and, thus, discourage effort to incorporate other functionality such as magnetic 
contrast, because the base nanoparticle is not appropriate for biomedical use.[11,12]   
However,  it has been demonstrated  that mesoporous silica nanoparticles of size 
between 25-255 nm have a low toxicity and high stability, for the same size compared to 
the non-porous silica nanoparticles. It has also been shown that toxicity values depend 
strongly from integrity of the mesopores.[13] Therefore it is important to choose the 
appropriate method of synthesis that allows to obtain silica nanoparticles  with 
mesoporous structure, with such sizes as to be stable, non-toxic, and easily used in 
different biomedical and pharmaceutical applications. In a  typical synthesis of 
hexagonal mesoporous silica (figure 5), the silicate source, tetraethylorthosilicate(TEOS), 
is  mixed with the cationic surfactant cetyltrimethylammonium bromide (CTAB) in a 
basic aqueous solution. The nanoparticles are formed using the micellar templates of 2.0 
to 2.5 nm in size which grow into mesoporous spherical nanoparticles with diameters of 
50 to 200 nm, during the base-catalysed sol–gel process. The cationic surfactant is 
assembled with silicates through electrostatic interaction, producing an ordered 
mesophase.  The mesoporous nanoparticles are obtained by subsequent removal of the 
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surfactant by extraction in acidic alcohol or calcination, due to the rupture of the 
electrostatic interaction between the cationic surfactant head groups and the anionic 
silicates.[14] It is possible to summarize the formation mechanism of mesoporous 
nanoparticles in three stages: (1) hydrolysis of alkoxysilanes and formation of silica 
oligomers, (2) formation of silica/CTAB primary particles, and (3) mesopore growth via 
aggregation of the primary particles.[15]  
 
Figure 5. A graphical representation of a typical sol–gel synthesis of mesoporous spherical nanoparticles 
from cetyltrimethylammonium bromide. 
 
Compared to hexagonal mesoporous silica, the  three-dimensional cubic (Ia3d) 
mesostructure has an interesting mesostructure, which consists of two interpenetrating 
continuous networks of chiral channels. This unique three-dimensional channel 
network is thought to provide a highly opened porous host that provides easy and direct 
access for guest species, thus facilitating inclusion or diffusion throughout the pore 
channels without pore blockage.
[6] This structure makes the material interesting for 
example, as a carrier for biologically active molecules.[16] Conventionally, the synthesis of 
MCM-48 materials is carried out through hydrothermal routes, but the hydrothermal 
synthesis methods typically take a long time, require high temperatures. Moreover, it 
gives a large particle size above 1 µm with irregular morphologies. In contrast to the 
hydrothermal recipes, the modified Stöber method, requires only a short synthesis time 
at room temperature.[17] The authors declare that this method produces monodisperse 
spherical MCM-48 mesoporous silica nanoparticles under the conditions of low cation 
surfactant (CTAB)/TEOS molar ratio, with high stirring rate. The addition of triblock 
copolymer Pluronic F127 (figure 6) as a nonionic surfactant decreases the size of silica 
nanoparticles, thanks to a favorable interaction of F127 with silicates through the 
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hydrogen bonds, limiting the growth of the mesostructure particle grain.[12]  Recently 
cubic mesoporous silica nanoparticles were obtained via base-catalysed sol-gel silica 
reactions using CTAB, TEOS, and functionalized with amino group, through the co-
condensation of the hight molar amounts of 3-aminopropyl triethoxysilane (APTES).[18]  
 
Figure 6. Pluronic F127 is a polymer  of  polyoxythylene  (PEO)  and  polyoxypropylene (PPO) with two  
96-unit hydrophilic PEO  chains surrounding one  69-unit hydrophobic PPO chain. 
 
In general, the factors that control the morphology, the mesoporous structure type, and 
size of silica nanoparticles, are: the cationic surfactant/TEOS molar ratio, time, stirring 
rate, the addition of a co-surfactant, or functional group, and no less important the chain 
length of cationic surfactant, because this has effect on the packing parameter, g 
(g=V/a0l, where V is the total volume of the surfactant chain plus any cosolvent 
molecules between the chains, a0 is the effective head-group area at the organic-
inorganic interface, and l is the surfactant chain length).[19] 
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5.3 Hexagonal and Cubic Mesostructured Silica nanoparticles (MSN_H, 
MSN_C): synthesis and characterization   
 
5.3.1 Synthesis 
Hexagonal mesostructured silica nanoparticles (MSN_H) have been synthesized 
starting from the following molar ratios: 0.82 TEOS: 8.3 NH3: 1 CTAB: 2.03 H2O: 1.87 
EtOAc, using  cetyltrimethylammonium bromide, CTAB (Aldrich, 96%), ammonia, 
NH4OH (Aldrich, 30%), tetraethylorthosilicate, TEOS (Aldrich, 98%), and ethylacetate, 
EtOAc (Aldrich, 99%), following the procedure schematically described in figure 7. In 
table 1 the reagents are listed, with the formulas and their functions in the reaction 
environment.  
 
Table 1. Reactants Information. 
Reagents 
 
Formula 
 
 
Manufacturer 
 
Purity 
 
Function 
 
CTAB 
Cetyltrimethylammonium 
Bromide 
 
 Aldrich 96% 
Templating 
Agent 
TEOS 
Tetraethylorthosilicate 
 
Aldrich 98% 
Precursor of the 
silica 
EtOAc 
Ethylacetate  
Aldrich 99% 
Inhibitor of 
growth of the 
nanoparticles 
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Figure 7. Schematic representation of  the synthesis of MSN_H mesoporous silica nanoparticles with 
hexagonal pore structure (H). 
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Cubic  mesostructured silica (MSN_C) nanoparticles have been obtained by a 
modification of the well-known Stöber method through a procedure schematically 
reported in figure 8, starting from the following molar ratios: 6.25 TEOS: 125 NH3: 540 
EtOH: 1 CTAB: 4170 H2O: 0.195 F127.
[12] As for the case of hexagonal mesoporous 
nanoparticles, silica nanoparticles have been obtained through base –catalyzed sol-gel 
process, using besides the cationic surfactant CTAB, an anionic surfactant like Pluronic 
F127. In table 2 has been reported the information about the reagents. 
 
Table 2. Reactants Information. 
Reagents 
 
Formula 
 
 
Manufacturer 
 
Purity 
 
Function 
 
CTAB 
Cetyltrimethylammonium  
bromide 
Aldrich 96% 
Templating 
Agent 
PLURONIC F127 
 
Aldrich - 
Inhibitor of 
growth of the 
nanoparticles 
TEOS 
Tetraethylorthosilicate 
 
Aldrich 98% 
Precursor of 
the silica 
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Figure 8. Schematic representation of  synthesis  of  the MSN_C mesoporous silica nanoparticles with 
cubic pore structure (C). 
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According to the synthesis described above, three samples for each type of silica 
(hexagonal and cubic) have been prepared: two samples in identical conditions to check 
the repeatability of the method (MSN_H_1, MSN_H_2; MSN_C_1, MSN_C_2;), and a 
third one with a concentration of ethylacetate 1.2 times higher than the other samples 
(MSN_H_3) or with a concentration of Pluronic F127 1.2 times higher than the other 
samples (MSN_C_3), to verify how this parameter can influence the particle size and 
structure of  the mesoporous silica nanoparticles. The tables 3a and 3b shows the 
synthesis conditions of the three samples. 
 
Table 3a. Synthesis conditions for the MSN_H samples. 
 
 
 
 
Table 3b. Synthesis conditions for the MSN_C samples. 
Sample 
TEOS 
(mol) 
NH3 
(mol) 
EtOH 
(mol) 
CTAB 
(mol) 
H2O 
(mol) 
F127 
(mol) 
Static 
time 
MSN_C_1 6.25 125 540 1 4170 0.19 24 h 
MSN_C_2 6.25 125 540 1 4170 0.19 24 h 
MSN_C_3 6.25 125 540 1 4170 0.23 24 h 
 
 
5.3.2 Microstructural and textural Characterization 
 
TEM analysis of the sample MSN_H_1  shows nanoparticles with spheroidal morphology 
(figure 9(a)) and evidences the ordered structure of the pores typical for an hexagonal 
arrangement (figure 9(b)). The particle size distribution histogram (figure 9(c)) shows a 
particle size range from 70 to 175 nm, with an average size of 124 nm and a standard 
deviation of 26 nm (polydispersity 21%). TEM measurements on the sample MSN_H_2 
Sample CTAB 
(mmol) 
H2O 
(mmol) 
NH4OH 
(mmol) 
TEOS 
(mmol) 
EtOAc 
(mmol) 
MSN_H_1 0.68 13.9 56.75 5.57 12.77 
MSN_H_2 0.68 13.9 56.75 5.57 12.77 
MSN_H_3 0.68 13.9 56.75 5.57 15.21 
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(figure 9(d) and 9(e)), confirm the repeatability of the procedure as regards both the 
morphology / texture of particles (shape and porosity), and the particle size 
distribution, being the average particle size value 129 nm and the standard deviation 25 
nm (polydispersity 19%).  
 
Figure 9. Bright Field TEM images at low and high magnification and particle size distribution 
histograms of the MSN_H_1 (a,b,c) and MSN_H_2 (d,e,f) mesoporous silica samples. 
 
The sample  MSN_H_3 (figure 10(a) and 10(b)), in which the concentration of ethyl 
acetate has been increased, show the formation of aggregated irregular shaped silica 
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nanoparticles. This would suggests that, above a certain concentration, the  ethyl acetate 
not only loses its primary function of size modulator and growth inhibitor but also can 
affect the CTAB templating agent action. 
 
Figure 10.  Bright Field TEM images of the MSN_H_3 sample (a,b). 
 
TEM images of the sample MSN_C_1,  show spherical nanoparticles (figure 11(a)) with a 
clear bimodal particle size distribution and evidence, for all the nanoparticles, the 
ordered pore structure typical for pores with cubic arrangement (figure 11(b)).  
 
 
Figure 11. Bright Field TEM images (a,b) and particle size distribution (c) of MSN_C_1 sample. 
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A fraction of the nanoparticles shows an average particle size centered at 75 nm, while di 
the other one is centered at about 140 nm. This result is in agreement with the literature: 
monodisperse low porous silica spheres prepared with the Stober method can be 
obtained solely when the silica particle size is bigger than 200 nm, while for the smaller 
particles this method leads often to a bimodal or multimodal distribution. The analysis 
of the sample MSN_C_2 confirms the presence of spherical nanoparticles with a bimodal 
size distribution, proving the repeatability of the synthesis. 
When the concentration of Pluronic F127 is increased (MSN_C_3) a small decrease on 
the size of the two nanoparticle fractions can be evidenced: the smaller particles are 
centered at ca. 65 nm (-10 nm) while the bigger one are centered at   125(-20 nm).This 
would suggests that the Pluronic acts as size modulator and growth inhibitor. In any 
case, to better verify this effect it should be useful to prepare a series of samples in which 
the concentration of the F127 is changed in a wider range. 
As expected, the wide-angle X-ray diffraction pattern of the thermally treated MSN_H 
and MSN_C samples (figure 12 (a) and (c)) shows the silica amorphous nature, as 
evidenced by the presence of a broad halo centered at about 2θ =23 °.  
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Figure 12. Wide angle XRD pattern of MSN_H_1 and MSN_C_1 samples (a and c) and Low angle XRD 
patterns of MSN_H and MSN_C samples before and after calcination at 550°C  in air (b and d). 
 
The Low-angle X-ray diffraction patterns (figure 12(b)), for the MSN_H_1 and MSN_H_2 
samples, before and after calcination, show three characteristic reflexes, 
(100),(110),(200), indicating a long-range ordering and a hexagonal pore structure 
(space group p6mm). It can be noticed that the samples after calcination show a shift of 
reflexes versus θ higher values and a corresponding decrease of the cell parameter (table 
4a),  probably due to contraction of porous structure caused by the elimination of the 
surfactant.[13] For all the MSN_C samples the low angle patterns evidence two 
characteristic reflexes, (211), (210), typical for a cubic pore structure (space group Ia3d). 
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As for the samples with exagonal pore structure, as expected, the calcination induces 
the a shift of the two reflexes versus higher θ values (table  4b) 
 
N2 adsorbtion-desorption isotherms (figure 13) for the MSN_H and MSN_C exhibit the 
characteristic IV behavior for  a well-developed micro-mesoporous structure.[20] The first 
step in a relative pressure range of  0.20-0.4 is attributed to the nitrogen condensation 
that took place at the internal mesopores, and second step above 0.95 in the adsorption 
represents the formation of interstitial pores. All the samples show high surface area 
(SBET) and  total pore volume (Vp), with mesopores diameter (Dpore) in the 2.3-2.6 nm 
range. The textural and structural parameters are reported in table 4. 
 
 
Figure 13. Nitrogen adsorption-desorption isotherms (a, c), and the pore size distribution (b, d) for 
MSN_H and MSN_C samples. 
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 Table 4a. Structural Parameters of MSN_H_1 and MSN_H_2  samples. 
*The lattice parameter (a0) was calculated  by  the equation; 
3
1002
0
d
a =
 through X-ray diffraction data. †The wall 
thickness (wBJH), was calculated from the difference between the lattice parameter (a0) and the pore size (Dpore). 
 
 
 
Table 4b.  Structural Parameters of MNS_C_1 and MNS_C_3  samples. 
*The lattice parameter (a0) was calculated  by  the equation: 21160 da ×=  through X-ray diffraction data. 
†The wall 
thickness (wBJH), was calculated by  the equation: 







 −
2092.3
0 poreDa  
 
The FTIR spectrum of the samples MSN_H  and MSN_C, before calcinations, (figure 14 
(a) and 14 (b)) exhibits a series of adsorptions attributable to the presence of CTAB 
(MSN_H) and CTAB/F127 (MSN_C): the symmetric (3010 cm-1), CH3 stretching modes, 
symmetric, asymmetric (2920-2850 cm-1) stretching, the bending (1450 cm-1), and the 
rocking (1400-720 cm-1) modes of CH2 group. Once the samples are subjected to 
Sample 
SBET 
(m2 g-1) 
Vp 
(cm3 g-1) 
(wBJH)† 
(nm) 
d100 
(nm) 
a0* 
(nm) 
Dpore 
(nm) 
MSN_H_1 - - - 3.8 4.4 - 
MSN_H_1_T 550°C 992 0.9 1.4 3.4 4.0 2.5 
MSN_H_2 - - - - 4.4 - 
MSN_H_2 T 550°C 1140 1.0 1.4 3.4 3.9 2.6 
Sample SBET 
(m2 g-1) 
Vp 
(cm3 g-1) 
(wBJH)† 
(nm) 
d211 
(nm) 
a0* 
(nm) 
Dpore 
(nm) 
MSN_C_1 - - - 3.5 8.7 - 
MSN_C_1 T 550°C 1441 0.9 1.3  3.2 7.7 2.3 
MSN_C_3 - - - 3.5 8.7 - 
MSN_C_3 T 550°C 1292 1.1 1.3  3.2 7.8 2.5 
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calcinations, the spectra show a series of bands typical of vibrational modes of pure 
silica: the symmetric stretching modes of the Si-O-Si group  at 1240 cm-1, 1060 cm-1, and 
800 cm-1, the stretching mode at 960 cm-1 of the Si-OH group, and the bending mode at 
460 cm-1 of  O-Si-O group. The absence of bands associated to CTAB or F127  suggests 
that the surfactants have been completely removed during the  calcinations treatment.  
 
Figure 14. FTIR spectra of the samples MSN_H_1 (a), MSN_C_1 (b) before and after calcinations in air. 
CTAB and F127 spectra have been also reported for comparison.  
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The thermogravimetric analysis of the MSN_H (figure 15(a) and MSN_C (figure 15(b)) 
samples  before the calcination show a first weight loss up to 200 °C due to desorption 
of physically adsorbed water, and a second one, from 200 °C to 550 °C due to the 
complete removal of the surfactants. The weight loss in this range is similar for all the 
samples (from 45 to 47%). Beyond  the temperature of 550 °C a small weight loss is 
observable due the collapse of the structure of the mesoporous silica, due to the 
condensation of the Si-OH groups to form adjacent Si-O-Si groups with the consequent 
elimination of the water molecules. For comparison, thermogravimetric analysis of the 
CTAB and the F127 has been reported.[21-23] As expected, the thermally treated samples 
show only a small weigh loss (2-3%) up to 200°C due to the adsorbed water.  
 
Figure 15. Thermogravimetric curves of the samples (a) MSN_H_1 and MSN_H_2;  (b) MSN_C_1 and 
MSN_C_3, before and after calcination in air. CTAB and F127 have been also reported for comparison. 
 
For a possible use of the silica nanoparticles in the biomedical field is of fundamental 
importance to study the stability of the colloidal suspensions in water. The products 
recovered by centrifugation at 10000 rpm has been washed several times in water and 
the stability over time has been studied up to four months. As can be seen from the 
images shown in figure 16 the samples MSN_H_1, MSN_H_2 (figure 16) and MSN_C_1, 
MSN_C_2 and MSN_C_3 (figure 17) are stable for over 4 months (figure 16(a) and (b)), 
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(figure 16(c)) become unstable after less than a week. The stability in water of the 
samples MSN_H_1 and MSN_C1  after the treatment at 550 °C has been also studied; the  
dried powder dispersed in water and submitted to several (5-6) short (15 seconds) 
ultrasound treatment cycles is stable up to 3 days. It has been taken into account that 
the stability over time has been studied solely through a visual observation and in order 
to study the phenomenon for the microscopic point of view it should be necessary to 
perform further characterizations. 
 
Figure 16.  Stability in water of MSN_H_1 (a), MSN_H_2 (b) after 4 months and of MSN_H_3 (c) after 
one week. 
 
 
Figure 17.  Stability in water of the MSN_C_1 (a), MSN_C_2 (b),  and MSN_C_3 (c) samples after 4 
months. 
 
 
5.4 Magnetic mesostructured silica based nanoparticles (MMSN_H and 
MMSN_C): Synthesis, characterization and magnetic properties 
 
5.4.1 Introduction 
 
As underlined in the other chapters, the hydrophobic magnetic nanoparticles prepared 
by HTDSA method, being dispersible in organic solvents, cannot be used, as such, for 
biomedical applications. In chapter 4 has been demonstrated how to convert them in 
hydrophilic systems through exchange ligand and intercalation processes, but the 
(a) (b) (c) 
(a) (b) (c) 
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corresponding molecular organic-functionalized nanoparticles could interact with other 
molecules in the biological environment, so that a more robust coating is often preferred 
for some applications. For this point of view, silica can be considered the ideal coating-
material, and sol-gel represents the most versatile approach in order to prepare magnetic 
low-porosity or high-porosity silica based systems. Recently, we have demonstrated that 
monodisperse low-porosity core-shell CoFe2O4-SiO2 nanoparticles can be prepared 
starting from hydrophobic nanoparticles and a base-catalyzed sol-gel process in the 
presence of an oil in water (cyclohexane/Igepal-CO520/water) microemulsion.[24] 
However, the low porosity of these systems can limit their applications, therefore, it 
should be very useful to set up new synthetic methodologies in order to prepare new 
magnetic composites with high mesoporosity. The high surface area and the presence of 
mesopores should allow the encapsulation of an high number of magnetic nanoparticles 
(high saturation magnetization), the entrapment of other inorganic nanoparticles with 
optical properties, and the physically or chemically bound of high concentrations of 
organic molecules. 
The proposed synthetic strategy is based on the use of a sol-gel process in the presence 
of “pseuso micelles”, made up of an inorganic core and an organic shell that ends with a 
polar head, that have been used as the building block for the formation of the mesophase.  
In this context, the molecule CTAB plays a key role: it allows the dispersion of 
hydrophobic magnetic nanoparticles into a polar solvent, the common reaction 
environment for sol-gel routes, and can be used as template (porogen agent) for the 
ordered pore structure. By analogy with the synthetic route used for pure 
mesostructured silica nanoparticles (paragraph 5.3), this strategy should lead to the 
formation of functionalizable magnetic mesostructured silica nanospheres with high 
surface area and high porous volume (figure 18).  
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Figure 18. Schematic illustration of the magnetic nanoparticles encapsulation into a mesoporous silica 
nanoparticles. 
 
 
5.4.2  MMSN_H Synthesis  
 
In order to prepare magnetic mesoporous silica nanospheres with hexagonal and cubic 
pore structure, hydrophobic magnetic nanoparticles made up of oleic acid/oleylamine 
capped magnetite (MAG_6nm for the MMSN_H composites, and MAG_12nm for the 
MMSN_C samples), have been first made hydrophilic by intercalation with CTAB 
molecules (MMSN_H composites) or with CTAB and F127 (MMSN_C composites), 
following a procedure similar to that described in chapter 4. Then, the resulting “pseudo 
micelles” have been used, instead of pure CTAB micelles, to create the hexagonal pore 
structure that has been coated, through a base-catalyzed sol-gel process, by TEOS and 
then silica. This soft-chemistry strategy should permit to entrap the preformed magnetic 
nanoparticles into mesostructured silica nanospheres without any significant 
modification of their magnetic properties. The synthesis procedures, schematically 
described in figure 18 (MMSN_H samples) and in figure 19 (MMSN_C), have been used to 
prepare two composites with hexagonal pore structure with 5% (MMSN_H_1) and 10% 
(MMSN_H_2) in weight of the magnetic phase and one composite with a cubic pore 
arrangement (MMSN_C_1) with 5% in weight of magnetite.  
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Figure 18.  Schematic representation of  synthesis  of MMSN _H  magnetic mesoporous silica composites 
with hexagonal pore structure (H). The amounts are referred to the sample MMSN_H_1 with 5% in 
weight of the magnetic phase. 
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Figure 19.  Schematic representation of  synthesis  of MMSN _C  magnetic mesoporous silica composites 
with cubic pore structure (H). The amounts are referred to the sample MMSN_C_1 with 5% in weight of 
the magnetic phase. 
 
5.4.3 Characterization 
 
TEM images (figure 20(b,c)) of the MMSN_H_1 revealed that the mesoporous silica 
spheroidal-hexagonal nanoparticles possess a well-ordered mesoporous structure and 
are quite uniform in size (polidispersity of 16%) with an average particle diameter of 
around 76 nm, which is within applicable size range for biomedical applications. Each 
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silica sphere contained several single magnetite nanocrystals of 6 nm in size (from ca 3 
to 10), and, as observed by the dark field mode image, the embedded magnetite 
nanocrystals retained the original size and crystallinity. The MMSN_H_2 sample, with 
the double concentration of the magnetic phase, still preserve the ordered pore 
arrangement, as well as the size and the shape. The particle size distribution, reported in 
figure 20, indicates an average particle size of 73 nm and a polidispersity of 15%; values 
just slightly lower than that obtained for the most diluted sample. It can be further 
notice that the magnetic particle are not homogeneously disperse inside the silica 
porous nanosphere, but rather they tend to cluster: this effect can be due to the magnetic 
interparticle interaction or to a different self-assembling process of the “CTAB-Oleic 
Acid-Magnetic Nanoparticle” micelles compared to that of the pure CTAB micelles. 
Another important result that derive from the incorporation of the preformed magnetic 
phase, is that the average size and polidispersity values of the nanoparticles are strongly 
reduced; this represents a great advantages for their possible application. A possible 
explanation of this behaviour can be found in the differences in the self-assembling 
phenomenon that derive from the differences in the porogen agent. The interactions 
among CTAB micelles for the formation of the mesophase are certainly different from the 
ones among the “pseudo hybrid micelles”.  
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Figure 20. TEM images, in Bright Field mode and at different magnifications (a,b), in Dark Field mode 
(c), and particle size distribution (d) of the sample  MMSN_H_1 (5% in weight). 
 
 
Figure 21. TEM images, in Bright Field mode and at different magnifications (a,b), in Dark Field mode 
(c), and particle size distribution (d) of the sample  MMSN_H_2 (10% in weight). 
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TEM analysis of MMSN_C_1 sample evidences a monodisperse system with spherical 
morphology of the particles (figure 22(a)). The monomodal particle size distribution 
(figure 22(d)) shows a size range from 95 to 135 nm, with average size of 110 nm and 
standard deviation of 8.6 nm ( polydispersity 8%). Bright field and dark field images 
show as all the silica particles contain from 1 to 5 magnetic nanoparticles, and no pure 
silica nanoparticles are observed; silica nanoparticle size gradually increases by 
increasing the number of encapsulated magnetic nanoparticles. As in the case of the 
hexagonal systems, the incorporation of the magnetic phase induces an improvement on 
the nanoparticle features: the particle size distribution from biomodal becomes 
monomodal and the polidispersity decreases.. Unfortunately, differently from the 
MMSN_ H samples, TEM images, also at high magnification, don’t allow to give 
information about the micro/mesoporosity or about the pore order.  
 
 
Figure 22. TEM images, in Bright Field mode and at different magnifications (a,b), in Dark Field mode 
(c), and particle size distribution (d) of the sample  MMSN_C_1 (5% in weight). 
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Figure 23(a) shows the wide angle XRD patterns of the magnetic mesoporous silica 
nanocomposite samples with hexagonal pores structure (MMSN_H_1 and MMSN_H_2), 
before and after calcination at 550°C. For comparison, the magnetic core of 6 nm in size 
(MAG_6nm) and the pure hexagonal mesoporous silica before and after thermal 
treatment (MSN_H_1) have been also reported. XRD pattern of the MMSN_H samples 
before thermal treatment revealed besides the halo associated to the amorphous silica, 
small and broad reflections due to the presence of the magnetic nanophase. Their 
intensity increases with the magnetic phase content, while their width is similar to that 
of the magnetic core, confirming that the size of the preformed magnetic nanoparticles is 
retained also after the treatment in air at 550°C. However, it has to be taken into 
account that the thermal treatment in air should lead to a complete oxidation of Fe(II) 
to Fe(III) with the consequent conversion of the magnetite into the maghemite phase 
with similar structure. Furthermore, the thermal treatment induces an evident shift of 
the silica band maximum versus higher 2θ values (from ca. 21° to ca. 23°): this effect, 
being clearly visible also in the pure silica sample, suggests a rearrangement of the Si-O-
Si and Si-OH bonds due to the elimination of the surfactants (CTAB and oleic acid). 
Similar results have been observed for the MMSN_C_1 sample with cubic pore structure 
(figure 23(b)), though the shift of the silica halo is very slighter if compared with the 
hexagonal porous systems thus suggesting a weaker interaction between silica and the 
surfactants (CTAB+F127). 
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Figure 23.  Wide-angle XRD patterns of the (a) MMSN_H_1 and MMSN_H_2  and of the (b) MMSN_C_1 
samples before and after calcination in air. For comparison the magnetic phases MAG_6nm and 
MAG_12nm and pure silica samples MSN_H_1 and MSN_C_1 before and after thermal treatment in air 
have been reported. 
 
Low-angle X-ray diffraction measurements have been also performed to extract 
information on the pores structure (figure 24(a)). The MMSN_H samples,  before and 
after thermally treatment in air,  show the three characteristic reflexes, (100),(110),(200), 
indicating a long-range ordering of the hexagonal pore structure (space group p6mm), 
confirming TEM data. It can be noticed that, as for the pure silica samples (MMS_H), 
the MMSN_H samples after calcination show a shift of reflexes at higher values of θ 
probably due to contraction of porous structure due to the surfactant removal. Unlike 
literature data, the ordering of the porous structure doesn’t decreases as the 
concentration of the guest phase increases, thus opening the possibility to synthetize 
mesoporous composites with higher amount of magnetic phase. 
Low-angle X-ray diffraction patterns for the MMSN_C_1 sample before and after 
thermally treatment in air (figure 24(b)) have been also performed in order to understand 
if the magnetic composite shows an ordered porous structure. The two characteristic 
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reflexes (211) and (220), indicate a cubic pore arrangement with the  space group Ia3d as 
to the pure silica sample (MSN_C) and the hexagonal-composites, the calcination 
induce the shift of reflexes at higher values of θ, due to the removal of CTAB and F127  
molecules and the consequent contraction of the pore structure.  
 
 
Figure 24.  Low-angle XRD patterns of the (a) MMSN_H_1 and MMSN_H_2  and of the (b) MMSN_C_1 
samples before and after calcination in air. For comparison pure silica samples MSN_H_1 and MSN_C_1 
before and after thermal treatment in air have been reported. 
In figure 25 are  reported the nitrogen adsorption-desorption isotherms (figure 25(a)) and 
the pore size distribution (figure 25(b)) of samples MMSN_H_1, and  MSN_H_1,  after 
calcination in air. 
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Figure 25.  N2-adsorption-desorption isotherms (a), and  pore size distribution (b) of the MMSN_H_1, 
and MSN_H_1 samples calcinated at 550°C. 
 
 
 
Figure 26.  N2-adsorption-desorption isotherms (a), and pore size distribution (b) of the MMSN_C_1, 
and MSN_C_1 samples calcinated at 550°C. 
 
The N2 adsorbtion-desorption isotherms of the thermal treated MMSN_H_1 composite 
(figure 25(a)) exhibit, as for the pure silica (MSN_H_1), the characteristic IV behavior for  
a well –developed micro-mesoporous structure. A step in a relative pressure range of  
0.20-0.4 is attributed to the nitrogen condensation that took  place at the internal 
mesopores, and second step above 0.95 in the adsorption represents the formation of 
interstitial pores. All measured structural and textural characteristics are listed in table 5. 
The MMSN_H_1 sample treated at 550°C in air have high Brunauer-Emmett-Teller 
(BET) surface area (992 m2/g)  and a large total pore volume (0.9 cm3/g). The Barret-
Joyer-Halenda (BJH) method was applied to calculate the pore size distribution, 
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indicating a maximum pore diameter of  2.7 nm. The incorporation of the magnetic 
phase with a concentration of 5% in weight, once again, doesn’t seem to change the 
features of the silica matrix, being the surface area of the pure hexagonal silica 1005 m2/g, 
the pore volume 1.1 cm3/g and the pore diameter 2.5 nm (table 5a). No significant effect 
has been revealed also on the thickness of the silica walls (1.5 nm against 1.4 nm).  
Similar features have been shown by the N2 adsorbtion-desorption isotherms of the 
sample MMSN_C_1 treated at 550°C with cubic pore structure (figure 26). The values of 
the surface area (SBET ~ 1300 m
2/g), of the  total pore volume (Vp ~ 0.9 cm
3/g) and of the 
pore diameter (Dpore~ 2.5 nm), are similar to the pure silica MSN_C_1 and higher than the 
composites with hexagonal pores structure. Differently to the most common 
impregnation methods, where to a porous matrix is added the precursor of the desired 
phase, which imply a reduction of  the surface area and of the pore volume, the proposed 
strategy, both for hexagonal and cubic systems, seems to preserve the textural 
properties of the matrix. 
Table 5a.  Textural and structural parameters of  MMNS_H_1 and MNS_H_1  samples. 
*The lattice parameter (a0) was calculated  by  the equation;     
3
1002
0
d
a =
                   through X-ray diffraction data. †The 
wall thickness (wBJH), was calculated from the difference between the lattice parameter (a0) and the pore size (Dpore). 
 
 
 
Sample 
SBET 
(m2 g-1) 
Vp 
(cm3 g-1) 
(wBJH)† 
(nm) 
D100 
(nm) 
a0* 
(nm) 
Dpore 
(nm) 
MMSN_H_1 - - - 4.0 4.6 - 
MMSN_H_1 T 550°C  Air 1005 1.1 1.5 3.6 4.1 2.7 
MSN_H_1 - - - 3.8 4.4 - 
MSN_H_1 T 550°C Air 992 0.9 1.4 3.4 4.0 2.5 
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Table 5b.  Textual structural parameters of MNS_C_1, and MMNS_C_1  samples. 
*The lattice parameter (a0) was calculated  by  the equation:
21160 da ×=  through X-ray diffraction data. 
†The wall 
thickness (wBJH), was calculated by  the equation: 







 −
2092.3
0 poreDa  
 
As for the pure silica samples, FTIR has been performed in order to verified the silica 
formation and the surfactant removal induced by the thermal treatment. The FTIR 
spectrum of the sample MMSN_H_1 (figure 27) and MMSN_C_1, (figure 28)  before 
calcinations, exhibits a series of adsorptions attributable to the presence of CTAB and 
F127: the symmetric (3010 cm-1), CH3 stretching modes, symmetric and  asymmetric 
(2920-2850 cm-1) stretching, the bending (1450 cm-1),and the rocking (1400-720 cm-1) 
modes of CH2 group. Once the sample is subjected to calcination, the spectra show only 
a series of bands typical of vibrational modes of pure silica: the symmetric stretching 
modes of Si-O-Si group (1240 cm-1, 1060 cm-1, 800 cm-1), of Si-OH group (960 cm-1), and 
the bending mode (460 cm-1) of  O-Si-O group. The absence of bands associated to 
CTAB and F127  suggests that the surfactants have been completely removed. The small 
band at 590 cm-1 in all samples are ascribed to the Me-O stretching of the magnetite 
phase. 
 
Sample SBET 
(m2 g-1) 
Vp 
(cm3 g-1) 
(wBJH)† 
(nm) 
d211 
(nm) 
a0* 
(nm) 
Dpore 
(nm) 
MSN_C_1  - - - 3.5 8.7 - 
MSN_C_1 T 550°C Air 1441 0.9 1.3 3.2 7.7 2.3 
MMSN_C_1 - - - 3.5 8.5 - 
MMSN_C_1 T 550°C Air 1306 0.9 1.3 3.2 7.7 2.5 
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Figure 27.  FTIR spectra of the CTAB and MMSN_H_1, before and after calcination.  
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Figure 28.  FTIR spectra of the CTAB,  F127 and MMSN_C_1, before and after calcination. 
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All the magnetic mesoporous silica nanoparticles (MMSN) result to be stable over time 
in water for about 2 months, as shown in figure 29. 
 
 
Figure 29. Stability in water of MMSN_H_1 sample. 
 
To understand how the mesoporous silica and the concentration of the magnetic phase 
could affect magnetic properties of the magnetite nanoparticles, the MAG_6nm 
(magnetic core), MMSN_H_1 ( magnetic phase 5% w/w), and MMSN_H_2 (magnetic 
phase 10% w/w) samples, have been submitted to preliminary magnetic measurements 
by SQUID. Temperature dependence of magnetization  has been investigated by ZFC-
FC protocols. Figure 30(a) show ZFC and FC magnetization curves of magnetic core 
MAG_6nm, and of the samples MMSN_H_1 and MMSN_H_2. 
 
Figure 30. ZFC (full symbols) and FC(empty symbols) magnetizations for MAG_6nm (black), 
MMSN_H_1 (blue) and MMSN_H_2 (red) (a); Hysteresis loop at 300K of MAG_6nm normalized for the 
magnetic phase (black) (b). 
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The quantitative comparison between Tmax, Tirr, values (table 6) gives some indications 
regarding the differences between the samples. As expected, Tirr follow the same trend of  
Tmax (figure 30), indicating superparamagnetic behavior at room temperature for all 
samples. Tirr and Tmax (table 6) clearly decrease with the incorporation of the magnetic 
phase (MMSN_H_1 sample) in the mesoporous diamagnetic matrix: this behavior can be 
ascribed to a decrease of the interparticle interactions due to the quite homogeneous 
dispersion of the magnetite nanoparticles onto the silica. No change in terms of size or 
crystallinity of the magnetic phase can be in fact supposed, being the preformed MAG-
6nm nanoparticles encapsulated at room temperature and without any further 
treatment. When the concentration of the magnetic phase is doubled, as observed by 
TEM analysis, the magnetic nanoparticles start to cluster and the average inter-particles 
distance decreases, and as a consequence the magnetic interaction become stronger. 
This effect is confirmed by the FC curve at low temperature. The difference between 
Tmax and Tirr, that provides a qualitative measure of the magnetic anisotropy distribution, 
and is strictly connected with the size distribution in the absence of interparticle 
interactions, are equal within the experimental error, further confirming that the 
magnetic phase  doesn’t undergo any modification when incorporated into the porous 
silica. 
Table 6.  Values of Tmax, , Tirr for MAG_6nm, MMSN_H_1 and MMSN_H_2 samples. 
Sample 
<DTEM> 
(nm) 
σ 
(%) 
Tmax 
(K) 
Tirr 
(K) 
Tirr-Tmax 
(K) 
*Ms (300 K) 
(A m2 Kg-1) 
MAG_6nm 6 10 18 25 7 36† 
MMSN_H_1  75 16 13 20 7  0.6 
MMSN_H_2 73 15 19 25  6  1.7 
*The values of MS have been normalized for the weight of the samples. †The value of Ms  for the sample 
MAG_6nm become 48 at 300K when only the magnetic phase is considered, in agreement with the 
literature data 
 
Field dependence of magnetization investigated a 300 K shows completely reversible 
behavior, confirming that all the samples are in superparamagnetic state. Saturation 
magnetization (Ms) is reported in table 6.  
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5.5 Conclusions 
Mesoporous silica nanoparticles (MSN) possess unique structural features such as their 
large surface areas, tunable nanometer-scale pore sizes, and well-defined surface 
properties. Versatile mesoporous silica nanoparticles and magnetic silica-based 
nanocomposite were fabricated. Here, we highlight the synthetic approach that involves 
the encapsulation of hydrophobic magnetic nanoparticles within a mesoporous silica 
with hexagonal or cubic pore structure. In both strategies the nanoparticles were 
encapsulated in MSNs using CTAB as both phase transfer agents and pore-generating 
templates. The presence of the inorganic magnetic core seems to improve the features of 
the silica nanoparticles, leading to systems with smaller particle size and narrower 
particle size distribution if compared with the pure silica materials. Furthermore, the 
magnetic properties of the guest phase and the textural properties of the matrix were 
preserved. Using magnetic composites (MMSN) as a scaffold, other functional 
components such as fluorescent dyes or quantum dots can been integrated within these 
systems to generate multifunctional nanocomposite systems that maintain their 
individual functional characteristics. Clever combinations of different types of 
functional nanostructured materials will therefore be enable to the development of 
multifunctional nanomedical platforms for multimodal imaging or simultaneous 
diagnosis and therapy.  
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Conclusions and future insights 
 
Uniform-sized colloidal nanocrystals have attracted much attention because of their 
unique magnetic and optical properties, as compared with those of their bulk 
counterparts. Especially, magnetic nanocrystals have been intensively pursued for 
biomedical applications, such as contrast enhancement agents in magnetic resonance 
imaging, magnetic carriers for drug delivery systems, biological labeling, and 
hyperthermia.  
In the present thesis, because magnetic properties are size and chemical composition 
dependent, the first objective that has been attained was the achievement of magnetite 
and cobalt ferrite nanoparticles as unique phases with tunable size and narrow particle 
size distribution. High temperature thermal decomposition of metallorganic compounds 
in highly boiling solvents assisted by surfactant has been selected as synthetic strategy,  
as it has been widely shown that the non-aqueous routes are more efficient in producing 
stable colloidal nanoparticles with narrow particle size distribution, high crystallinity 
and tunable size and shape. Changing the solvent, the temperature, the time and the 
concentration of the surfactants it has been possible to change the size of the magnetic 
phases from about 4 to 12 nm.   
However, this approach produce hydrophobic nanoparticles, being the nanoparticle 
surface capped with oleic-acid and oleylamine, limiting their applications in biological 
and medical fields. Thus, the second important objective of this work was the 
transferring of these nanoparticles into water. The engineering of the surface has been 
carried out through two main strategies based on ligand exchange and intercalation 
processes. Small double functionalized molecules, as dimercapto-succinic acid and 
succinic acid, and silanes with COOH or PEG as functional groups, have been used as 
ligands to substitute the starting capping agents (oleic acid-oleylamine). The 
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characterization of the systems indicates that, in all the cases, the ligand exchange is 
almost complete, even if the presence of small amount of oleic acid cannot be excluded. 
Anyway all the ferrofluid are water dispersible and are stable for months. Intercalation 
phenomena can be induced by the using of molecules like cetyltrimetilmmonium 
bromide (CTAB) and the corresponding water dispersions are very stable. All these 
aqueous ferrofluids can be used in MRI,  in hyperthermia application and also for 
protein purification by magnetic separation.  
 
 
 
The conversion of the hydrophobic nanoparticles into hydrophilic systems has been 
performed also by their encapsulation onto a silica mesoporous matrix. Due to their 
large pore size and high surface area, mesoporous materials and their composites with 
nanocrystals have attracted considerable attention. To use nanocrystals as functional 
delivery carriers and catalytic supports, nanocrystals coated with porous silica shells are 
desirable and to our knowledge there have been a few reports on their preparation. Silica 
is an ideal candidate, being biocompatible, having a low toxicity (size and surface area 
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dependent), high surface silanol groups and low density. In addition, mesoporous silica 
nanoparticles due to their high surface area and pore size can entrap magnetic 
nanoparticles and, at the same, time can be further functionalized with amino, mercapto, 
carboxy, cyano, phenyl, benzyl groups extending their range of possible applications. 
Thus, starting with the preparation of colloidal silica nanoparticles with ordered 
hexagonal or cubic structure and with ideal sizes for the applications in biomedicine, it 
has been possible to set up a synthetic strategy that has allowed to entrap the preformed 
hydrophobic nanoparticles within a mesostructured silica without changing the 
physical properties of the magnetic phase and the peculiar features of the matrix. The 
key molecule that has allowed the success of the synthetic strategy has resulted to be the 
ionic surfactant CTAB used both to intercalate oleic acid and as template for the 
formation of silica ordered porous structure. The “pseudo hybrid micelles” made up of an 
inorganic core and an organic shell of oleic acid-CTAB has been used instead of CTAB 
micelles to build the organic mesophase, that through a based catalyzed sol-gel process, 
has been coated with silica. Following this approach, magnetic mesoporous systems 
with hexagonal pore order has been achieved, and with the adding of the non-ionic 
surfactant F127 has been also possible to prepare magnetic composites with a cubic 
order. Size and particle size distributions are ideal for biomedical applications because 
of the low cytotoxicity that is size dependent.  
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The high potentiality of these systems derive from the possibility to make them 
multifunctional when to the magnetic nanoparticles are associated fluorescent or 
luminescent species as nanoparticles or molecules. Moreover, compared to non-porous 
silica nanoparticles, mesoporous silica materials can not only reduce red blood cell 
membrane damage but also provide a large surface area for drug loading. For these 
reasons I believe that these magnetic nanoparticles have great potential for bioimaging 
and drug delivery applications. 
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Appendix 
Equipments and Techniques 
    
Several techniques have been used to obtain information on the  system under investigation. In fact, 
only a multi-technique approach allow to elucidate their nanostructure and their properties. 
 
Transmission Electron Microscopy (TEM) 
 
Transmission Electron Microscopy (TEM) micrographs were obtained using a JEOL 
200CX microscope operating at 200 kV. Colloidal dispersions have been dropped on 
conventional copper grids for the observations. Under the experimental conditions 
adopted, the wavelength of the incident beam is about 2.51× 10-2 nm and the camera 
length is 82 cm. Particle size distributions have been obtained by bright field images, on 
different images the average diameter of about 200 particles in different parts of the grid. 
The standard deviation σ,  was calculated from the following equation: 
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High Resolution Transmission Electron Microscopy (HRTEM) 
 
High Resolution (HR) TEM images were performed using a JEM 2010UHR (Jeol) 
microscope with a LaB6 thermionic source operating at 200 kV and equipped with a 
Gatan Imaging Filter (GIF). Energy-filtered images were acquired using a 3 mm GIF 
entrance aperture and a slit width of 15 eV. All high-resolution images were acquired 
147 
 
digitally at microscope magnification of 25 kX, using 1 s or 2 s exposure and 1 x binning 
(1024 x 1024 pixel) of the charge coupled device (CCD) camera (a 794 slow scan). 
Because of the ≈ 19x magnification between the TEM viewing screen and the CCD 
camera, a preliminary calibration using a standard gold sample were performed to obtain 
corrected values of d-spacing in the samples. 
X-Ray Diffraction 
Powder X-Ray Diffraction (XRD) spectra of the samples were collected using a Seifert 
diffractometer with a conventional θ-θ Bragg-Brentano focalising geometry, Cu-Kα 
wavelength. An estimate of mean particle size (<DXRD>) was obtained from XRD 
patterns. The relation between average crystal size without disorder effects and full 
width at half maximum (fwhm) is expressed by Scherrer’s equation: 
 
 
 
where λ is the wavelength of X-Ray, θ is the angle of incident of X-ray beam, K is a 
constant related to the crystallite shape (0.9) and β is the pure breath of the powder 
reflection free of the broadening due to instrumental contributions. This calibration was 
performed by means of the spectrum of a standard Si sample and using the Warren 
correction βsample =(βexp2 - βstd2). 
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Infrared Spectroscopy 
The absorption spectra were collected in the Mid region from 400 cm-1 to 2000 cm-1 
using an Equinox 55 (Bruker) spectrophotometer. The samples were prepared in 
pellets obtained by dispersing the finely ground powder in KBr. 
Nitrogen–physisorption measurements 
N2-physisorption measurements at 77 K were carried out on a Sorptomatic 1990 System 
(Fisons Instruments). Before analysis, the samples were outgassed by heating at a rate of 
1°C min-1 under vacuum at 200°C for 18 hours.  
Thermogravimetry and Differential thermal Analysis 
Thermogravimetry analysis (TGA) and simultaneous differential thermal analysis 
(SDTA) of the samples were carried out on a Mettler-Toledo TGA/SDTA 851. Thermal 
analysis data were collected in the range 25-1000°C with an heating rate of 10°C min-1 
under oxygen flow (flow rate = 50 ml/min-1). 
Chemical Analysis (ICP-AES) 
The determination of cobalt and iron concentrations in the samples was performed in 
triplicate by a Varian Liberty 200 Inductively Coupled Plasma Atomic Emission 
Spectrometer (ICP-AES). Before the analysis,  1 mL of sample was digested on a hot plate 
at 80 °C for 6 h with 2 mL of aqua regia (HCl 37%  grade and HNO3, 65% sub-boiled in 
3:1 ratio) and 0.05 mL of H2O2 suprapure grade. After digestion, the samples were 
diluted to 100 mL with distilled water. Analysis was performed using multiple standard 
additions method. 
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Magnetic measurement 
The magnetic measurements were carried out with a Superconducting Quantum Interference 
Device (S.Q.U.I.D.) The S.Q.U.I.D. magnetometer is, actually, the most sensitive 
magnetometer. It contains an superconducting magnet able to produce magnetic fields 
from zero to several positive and negative Tesla. In addition, it allows a precise control of 
the sample temperature from the liquid Helium temperature (4.2K) to 400K. The 
measurements of Magnetization versus temperature, performed with the ZFC and FC 
protocols, are one of the most classical approaches in order to observe 
superparamagnetic relaxation in nanoparticles. The ZFC protocol consists in cooling 
the sample from high temperature, where all the particles are in superparamagnetic 
state, to the lowest measuring temperature in zero magnetic field. Then a static 
magnetic field is applied and magnetization is measured during warming up (MZFC). 
The resulting curve is called Zero Field Cooled because the sample has been previously 
cooled in absence of a magnetic field. When the nanoparticles are cooled below the 
blocking temperature without magnetic field, all the net magnetic moments in each 
single domain particle point along the easy axis of the nanoparticles. The FC protocol 
consist in cooling the sample in a small DC field and measuring the magnetization 
during warming up without remove the field. When a magnetic field is applied during 
the cooling process (FC), all the net magnetic moments of the nanoparticles are aligned 
along the field direction. As the nanoparticles are cooled at low temperature, the 
magnetization direction of each particle is frozen in the field direction. By increasing the 
temperature, an increasing number of particles will be in superparamagnetic state and 
the magnetization monotonically will decrease giving rise to a typical “paramagnetic 
behaviour”. ZFC FC magnetization measurements were carried out by cooling the 
sample from 325K to 5K in zero magnetic field. Then a static magnetic field was applied. 
MZFC was measured during warming up from 4.2 to 325K, whereas MFC was recorded 
during the subsequent cooling. Stringently both MZFC and MFC should be measured in 
warming up. 
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